Phenalene-1-one containing photosensitizer compositions, phenalene-1-one compounds and their uses
Patent Information
- Application Number
- DE502017016554
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2017-03-17
- Publication Date
- 2024-12-05
- Estimated Expiration
- 2037-03-17
AI Technical Summary
Existing photosensitizer compositions for antimicrobial surfaces face issues with leaching and reduced effectiveness over time, and mechanical stress can detach photosensitizers, leading to decreased antimicrobial performance.
A photosensitizer composition comprising a phenalen-1-one compound covalently or electrostatically bound within a cured polymer matrix, ensuring improved adhesion and sustained antimicrobial activity upon exposure to specific electromagnetic radiation.
The composition maintains high antimicrobial effectiveness by preventing photosensitizer leakage and detachment, providing reliable inactivation of microorganisms even after prolonged irradiation, with a significant reduction in microorganism viability exceeding 99.9%.
Description
[0001] The present invention relates to a photosensitizer composition, a phenalen-1-one compound, an article and their non-medical use.
[0002] The active or passive penetration, adhesion, and proliferation of pathogens in a host is referred to as an infection. Sources of infectious particles occur everywhere. For example, the human body is colonized by a large number of microorganisms, which are usually kept under control by normal metabolism and an intact immune system. However, if the immune system is weakened, for example, this can lead to a rapid proliferation of pathogens, resulting in different symptoms depending on the type of pathogen. Medicine has specific antidotes for many pathogen-related diseases, for example antibiotics against bacteria, antimycotics against fungi, or antivirals against viruses. However, the use of these antidotes has led to an increased emergence of resistant pathogens, some of which are resistant to several antidotes simultaneously.The emergence of these resistant or multidrug-resistant pathogens has made the treatment of infectious diseases increasingly difficult. The clinical consequence of resistance is treatment failure, especially in immunosuppressed patients.
[0003] New approaches to combating resistant or multi-resistant pathogens are therefore, on the one hand, the search for new antidotes, such as antibiotics or antimycotics, and, on the other hand, the search for alternative inactivation options.
[0004] Photodynamic inactivation of microorganisms has proven to be an effective alternative method. Two different photooxidative processes play a crucial role in the photodynamic inactivation of microorganisms. The prerequisites for photooxidative inactivation are, on the one hand, the presence of a sufficient amount of oxygen and, on the other hand, the localization of a so-called photosensitizer, which is excited by light of a corresponding wavelength. The excited photosensitizer can cause the formation of reactive oxygen species (ROS), which can lead to the formation of radicals, such as superoxide anions, hydrogen peroxide, or hydroxyl radicals, and / or excited molecular oxygen, such as singlet oxygen.
[0005] In both reactions, the photooxidation of specific biomolecules, which are located in direct proximity to reactive oxygen species (ROS), is paramount. This primarily involves the oxidation of lipids and proteins, which are found, for example, as components of the cell membrane of microorganisms. The destruction of the cell membrane, in turn, leads to the inactivation of the microorganisms in question. A similar elimination process is assumed for viruses and fungi.
[0006] For example, all molecules are attacked by singlet oxygen. However, unsaturated fatty acids in bacterial membranes are particularly susceptible to damage. Healthy, endogenous cells possess a cellular defense against free radical attacks, called catalases or superoxide dismutases.
[0007] Therefore, healthy, endogenous cells can counteract damage caused by reactive oxygen species (ROS), such as radicals or singlet oxygen.
[0008] Numerous photosensitizers are known from the state of the art, which originate, for example, from the group of porphyrins and their derivatives or phthalocyanines and their derivatives or fullerenes and their derivatives or derivatives of the phenothiazininium structure, such as methylene blue or toluidine blue, or representatives of the phenoxazinium series, such as Nile blue.
[0009] WO 00 / 78854 A1 relates to a method for providing an antimicrobial surface, the method comprising combining one or more polymers with one or more photosensitizers to form a surface comprising a cured polymer composition comprising one or more polymers and one or more non-covalently and non-ionically bound photosensitizers, at least one of which is a xanthene photosensitizer.
[0010] The disadvantage is that the photosensitizer leaches from the polymer matrix and thus the antimicrobial effectiveness decreases during longer storage.
[0011] US Pat. No. 5,830,526 A discloses a substrate to which a light-activatable dye is bound, alone or in combination with additional conventional antimicrobial and / or antiviral agents. The substrate is impregnated with a light-activatable dye with antimicrobial and / or antiviral properties, with a cationic or anionic water-soluble polymer binding the dye to the substrate.
[0012] The disadvantage is that the photosensitizer can be detached from the substrate, for example due to mechanical stress, thus reducing the antimicrobial effectiveness.
[0013] WO 2012 / 113860 A2 is directed to the provision of phenalen-1-one derivatives, processes for the preparation and use thereof.
[0014] The object of the present invention is to provide a photosensitizer-containing coating which ensures easy application to preferably different types of surfaces and, in particular, at the same time shows good antimicrobial effectiveness after exposure to electromagnetic radiation of suitable wavelength and intensity.
[0015] Furthermore, the photosensitizer-containing coating should preferably ensure improved adhesion of the photosensitizer after application to a surface, so that bleeding of the photosensitizer is preferably avoided.
[0016] Furthermore, the effectiveness of the photosensitizer should preferably be improved, especially during prolonged irradiation with electromagnetic radiation of suitable wavelength and intensity.
[0017] The photosensitizer-containing coating should essentially not hinder the excitation of the photosensitizer molecules contained in the coating by light of a specific wavelength.
[0018] The object of the present invention is achieved by providing a photosensitizer composition according to claim 1.
[0019] Preferred embodiments of the photosensitizer composition according to the invention are specified in claims 2 to 3 and 6 to 11.
[0020] The object of the present invention is also achieved by providing a phenalen-1-one compound according to claim 4.
[0021] Preferred embodiments of the phenalen-1-one compound according to the invention are specified in claim 5.
[0022] The object of the present invention is further achieved by providing an article according to claim 12.
[0023] Preferred embodiments of the subject matter according to the invention are specified in claims 13 to 14.
[0024] The object of the present invention is also achieved by providing a non-medical use according to claim 15, wherein a photosensitizer composition according to any one of claims 1 to 3 or 6 to 11 and / or a phenalen-1-one compound according to any one of claims 4 to 5 and / or an article according to any one of claims 12 to 14 is used for the, preferably photodynamic, inactivation of microorganisms, which are preferably selected from the group consisting of viruses, archaea, bacteria, bacterial spores, fungi, fungal spores, protozoa, algae and blood-borne parasites, and / or a biofilm thereof.
[0025] Preferred embodiments of the non-medical use according to the invention are specified in claims 16 to 17.
[0026] The term "biofilm" is preferably understood to mean a matrix of extracellular polymeric substances (EPS), which are preferably formed by microorganisms and released by them into their immediate environment adjacent to the cell, in which microorganisms, preferably bacteria, algae, fungi, protozoa or combinations thereof, are at least partially arranged or embedded.
[0027] The object of the present invention is also achieved by providing a non-medical method for the, preferably photodynamic, inactivation of microorganisms, which preferably comprise viruses, archaea, bacteria, bacterial spores, fungi, fungal spores, protozoa, algae, blood-borne parasites or combinations thereof and / or a biofilm thereof, according to claim 18, wherein the method comprises the following steps: (A) bringing the microorganisms and / or a biofilm thereof into contact with at least one coating which was produced by curing a photosensitizer composition according to any one of claims 1 to 3 or 6 to 11 and / or contains at least one phenalen-1-one compound according to any one of claims 4 to 5, and / or at least one article according to any one of claims 12 to 14, and (B) irradiating the microorganisms and / or a biofilm thereof and the at least one phenalen-1-one compound contained in the coating and / or the article with electromagnetic radiation of suitable wavelength and energy density.
[0028] The term "curing" or "hardening" preferably refers to the transition from a liquid or plastically deformable state to a solid state of a substance or mixture of substances under standard conditions (temperature: 25°C, pressure: 1013 mbar).
[0029] The process of curing or hardening can preferably be carried out by cooling, ie by reducing the temperature below the freezing point and / or glass transition temperature of a substance or mixture of substances, physical drying, ie by removing at least one liquid component, for example solvent, and / or by chemical reaction, for example by chain polymerization, polyaddition and / or polycondensation.
[0030] The term "polymeric component and / or precursor thereof" is preferably understood to mean a substance or mixture of substances which comprises at least one, preferably organic, polymer and / or at least one precursor thereof.
[0031] The term "polymer" preferably refers to a substance composed of preferably at least 10 structural units, so-called constitutional repeating units, which may be identical or different from one another and which form at least one organic polymer through chemical reaction, preferably chain polymerization, polyaddition, and / or polycondensation. A constitutional repeating unit (CRU) is preferably the smallest repeating group of atoms within a polymer.
[0032] A polymer within the meaning of the invention can be unbranched or branched.
[0033] The term "precursor of a polymeric component" preferably refers to monomers or monomer mixtures as well as oligomers and mixtures thereof, which can each combine to form the corresponding unbranched or branched polymer, preferably by chemical reaction, more preferably chain polymerization, polyaddition and / or polycondensation.
[0034] The term "reactive functional group" is preferably understood to mean a functional group which can participate in the formation of the corresponding unbranched or branched polymer by chemical reaction, more preferably chain polymerization, polyaddition and / or polycondensation.
[0035] Monomers or monomer mixtures within the meaning of the invention are preferably low-molecular-weight, reactive molecules or mixtures of reactive molecules that can each combine to form the corresponding unbranched or branched polymer by chemical reaction, more preferably chain polymerization, polyaddition, and / or polycondensation, thereby forming a constitutional repeating unit of the polymer. Preferably, a reactive molecule, for example, a monomer, oligomer, and optionally a polymer, has at least one reactive functional group.
[0036] The term "oligomer" is preferably understood to mean a substance which is composed of preferably 2 to 9 constitutional repeating units, which may be the same or different from one another and which may combine to form an unbranched or branched polymer, preferably by chemical reaction, more preferably chain polymerization, polyaddition and / or polycondensation.
[0037] The term "cured polymeric component" preferably refers to a polymeric substance or a mixture of polymeric substances which has a solid state under standard conditions (temperature: 25°C, pressure: 1013 mbar) and is preferably not plastically deformable.
[0038] For the definition of the above terms, please refer to Jenkins, AD et al.: "Glossary of basic terms in polymer science (IUPAC Recommendations 1996)" (Pure Appl. Chem. 68 (12), 1996, pages 2287 to 2311, doi:10.1351 / pac199668122287).
[0039] Preferably, a photosensitizer composition according to the invention forms, after curing, a cured polymer composition which contains at least one compound of the formula (1) used according to the invention and / or at least one compound of the formula (1a) according to the invention.
[0040] In a preferred embodiment, during curing of a photosensitizer composition according to the invention, the at least one compound of formula (1) used in the invention and / or the at least one compound of formula (1a) used in the invention is covalently and / or electrostatically, preferably covalently, bound in the cured polymer composition. Further preferably, during curing of a photosensitizer composition according to the invention, the at least one compound of formula (1) used in the invention and / or the at least one compound of formula (1a) used in the invention is covalently and / or electrostatically, preferably covalently, bound to the at least one cured polymer component.
[0041] This preferably prevents at least partially, preferably completely, the at least one compound of the formula (1) used according to the invention and / or the at least one compound of the formula (1a) according to the invention from escaping from the cured photosensitizer composition.
[0042] The compound of formula (1) used according to the invention and the compound of formula (1a) according to the invention are each a 1H-phenalen-1-one derivative, which is also referred to as such hereinafter.
[0043] Preferably, a compound of formula (1) used according to the invention and a compound of formula (1a) according to the invention each have no neutral, protonatable nitrogen atom, for example as an amino radical, methylamino radical or dimethylamino radical, and no positively charged, preferably quaternary, nitrogen atom, for example as a pyridin-1-ium-1-yl radical or trimethylammonio radical, and no positively charged, preferably quaternary, phosphorus atom which is directly bonded to the phenalene ring.
[0044] "Direct" means that the nitrogen atom and / or the phosphorus atom is directly bonded to the phenalene ring.
[0045] The inventors have found that a direct arrangement of the nitrogen atom and / or phosphorus atom on the phenalene ring leads to a significant reduction of the singlet oxygen quantum yield.
[0046] The highest possible singlet oxygen quantum yield is required for antimicrobial efficacy in photodynamic therapy or photodynamic cleaning or disinfection of surfaces. When the nitrogen atom and / or phosphorus atom are directly attached to the phenalene ring, the absorbed energy is predominantly dissipated through fluorescence effects, leading to a significant reduction in the singlet oxygen quantum yield.
[0047] Preferably, a compound of formula (1) used according to the invention and a compound of formula (1a) according to the invention each have no OH group and / or no deprotonated OH group directly bonded to the phenalene ring.
[0048] "Direct" means that the OH group and / or deprotonated OH group is directly bonded to the phenalene ring.
[0049] The inventors have found that the direct attachment of an OH group and / or deprotonated OH group to the phenalene ring results in a significant deterioration in the photostability of the photosensitizer. This deterioration in photostability leads to faster bleaching and thus to faster inactivation of the photosensitizer upon irradiation with electromagnetic radiation of a suitable wavelength.
[0050] "Photosensitizer" is preferably understood to mean compounds that absorb electromagnetic radiation, preferably visible light, UV light and / or infrared light, and then generate reactive oxygen species (ROS), preferably free radicals and / or singlet oxygen, from triplet oxygen.
[0051] A photosensitizer according to the invention preferably has the general formula (1) and / or the general formula (1a).
[0052] The term "photodynamic disinfection" preferably refers to the light-induced inactivation of cells or microorganisms and / or a biofilm thereof on the surfaces of objects.
[0053] The term "photodynamic cleaning" preferably refers to the light-induced reduction of the number of cells or microorganisms and / or a biofilm thereof on the surfaces of objects.
[0054] According to the invention, the term "inactivation" refers to the reduction of the viability or destruction of a microorganism, preferably its destruction. Light-induced inactivation can be determined, for example, by reducing the number of microorganisms after irradiation of a defined initial amount of these microorganisms in the presence of at least one compound of the invention having formula (1a) and / or at least one compound of the invention having formula (1).
[0055] Preferably, reducing the viability or destroying microorganisms of a biofilm, preferably destroying it, can reduce or prevent the release of extracellular polymeric substances that form the matrix of a biofilm. This preferably slows or suppresses the formation of a biofilm.
[0056] According to the invention, a reduction in viability is understood to mean that the number of microorganisms, for example in a biofilm, is reduced by at least 90.0%, preferably at least 95.0%, preferably at least 99.9%, more preferably by at least 99.99%, more preferably by at least 99.999%, even more preferably by at least 99.9999%. Most preferably, the number of microorganisms is reduced by more than 99.9 to 100%, preferably by more than 99.99 to 100%.
[0057] Preferably, the reduction in the number of microorganisms is given as a log10 reduction factor according to Boyce, JM and Pittet, D. ("Guidelines for hand hygiene in healthcare settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC / SHEA / APIC / IDSA Hand Hygiene Task Force", Am.J.Infect.Control 30 (8), 2002, pages 1 - 46).
[0058] According to the invention, the term "log 10 reduction factor" is understood to mean the difference between the decimal logarithm of the number of microorganisms before and the decimal logarithm of the number of microorganisms after irradiation of these microorganisms with electromagnetic radiation in the presence of at least one compound of the invention having formula (1a) and / or at least one compound of the invention having formula (1). For example, the microorganisms can be contained in a biofilm.
[0059] Suitable methods for determining the log 10 reduction factor are described, for example, in DIN EN 14885:2007-01 "Chemical disinfectants and antiseptics - Application of European standards for chemical disinfectants and antiseptics" or in Rabenau, HF and Schwebke, I. ("Guideline of the German Association for the Control of Viral Diseases (DW) e. V. and the Robert Koch Institute (RKI) for testing chemical disinfectants for efficacy against viruses in human medicine" Federal Health Gazette, Health Research, Health Protection 51(8), (2008), pages 937 - 945).
[0060] Preferably, the log 10 reduction factor after irradiation of microorganisms and / or a biofilm thereof with electromagnetic radiation in the presence of at least one compound according to the invention having the formula (1a) and / or at least one compound used according to the invention having the formula (1) is at least 1 log 10 , preferably at least 2 log 10 , preferably at least 3 log 10 , more preferably at least 4 log 10 , more preferably at least 4.5 log 10 , more preferably at least 5 log 10 , more preferably at least 6 log 10 , even more preferably at least 7 log 10 .For example, a reduction in the number of microorganisms after irradiation of these microorganisms and / or a biofilm thereof with electromagnetic radiation in the presence of at least one compound according to the invention having the formula (1a) and / or at least one compound used according to the invention having the formula (1) by 2 orders of magnitude, based on the initial amount of these microorganisms, means a log 10 reduction factor of 2 log 10 .
[0061] More preferably, the number of microorganisms after irradiation of these microorganisms and / or a biofilm thereof with electromagnetic radiation in the presence of at least one compound according to the invention having the formula (1a) and / or at least one compound used according to the invention having the formula (1) is reduced by at least 1 power of ten, more preferably by at least 2 powers of ten, preferably by at least 4 powers of ten, more preferably by at least 5 powers of ten, more preferably by at least 6 powers of ten, even more preferably by at least 7 powers of ten, in each case based on the initial amount of these microorganisms.
[0062] For the purposes of the invention, the term "microorganisms" refers in particular to viruses, archaea, prokaryotic microorganisms such as fungi, protozoa, fungal spores, and unicellular algae. These microorganisms can be unicellular or multicellular, for example, fungal mycelium.
[0063] According to the invention, a halogen is understood to mean, independently of one another, fluorine, chlorine, bromine, or iodine. According to the invention, a halide is understood to mean, independently of one another, fluoride, chloride, bromide, or iodide.
[0064] Chiral centers can be present in the R or S configuration, unless otherwise stated. The invention relates to both the optically pure compounds and stereoisomer mixtures, such as enantiomer mixtures and diastereomer mixtures, in any ratio.
[0065] The invention preferably also relates to mesomeres and / or tautomers of the compound of formula (1) and / or formula (1a), both the pure compounds and the isomer mixtures in any ratio.
[0066] Unless otherwise stated, an * in a formula indicates a point of connection between two residues.
[0067] A preferably curable photosensitizer composition according to the invention comprises: (a) at least one phenalen-1-one compound to be used according to the invention having the general formula (1): and (b) at least one polymeric component and / or precursors thereof.
[0068] A phenalen-1-one compound to be used according to the invention has the general formula (1), wherein the radicals R1 to R8, which may each independently be the same or different from one another, each represent hydrogen, halogen, alkyl having 1 to 12 C atoms, preferably 2 to 9 C atoms, alkylaryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, aryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, *-O-alkyl having 1 to 12 C atoms, preferably 2 to 9 C atoms, *-O-alkylaryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, *-O-aryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, ether having 2 to 12 C atoms, a radical of Formula *-OC(=O)-R (Ia)< , a radical of the formula *-C(=O)-R (Ib)< , or an organic radical W1 which contains at least one reactive functional group, with the proviso that at least one of the radicals R1 to R7, preferably at least one of the radicals R1, R2, R5 or R6,more preferably at least one of the radicals R1 or R2, preferably one of the radicals R1 or R2, is an organic radical W1, where the organic radical W1 is in each case independently a radical having the general formula (2) to (6): *-[(C(D)(E)) d -B) a -(C(D)(E)) m -X (2) *-A-[(C(D)(E)) d -B] c -(C(D)(E)) m -X (3) *-(C(D)(E)) d -Ar-(C(D)(E)) n -X (4) *-[(C(D)(E)) d -B] b -(C(D)(E)) g -Ar-(C(D)(E)) n -X (5) *-A-[(C(D)(E)) d -B] f -(C(D)(E)) g -Ar-(C(D)(E)) n -X (6) means, where the radical A each independently represents oxygen, sulfur or a radical having the general formula (10a) to (11a), preferably oxygen or a radical having the general formula (10a) to (11a), more preferably oxygen or a radical having the general formula (10a), more preferably oxygen: where * ph< denotes in each case a point of attachment of the radical with the general formula (10a) to (11a) to a C atom of the phenalene ring and * c< denotes in each case a point of attachment of the radical with the general formula (10a) to (11a) to a C atom of the radical (C(D)(E)), where the radical B each independently denotes oxygen, sulfur or a radical with the general formula (10) to (14), preferably oxygen or a radical with the general formula (10) to (14), more preferably oxygen or a radical with the general formula (10): where the radicals R (Ia)< , R (Ib)< , R (11a)< , R (12a)< , R (13a)< , R (14a)< and R (14b)< , each independently of one another, denote hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, iso-butyl, n-pentyl, phenyl or benzyl, and where phenyl and benzyl are each independently unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, amino, hydroxyl, alkyl, which may be straight-chain or branched, having 1 to 3 carbon atoms, hydroxyalkyl, which may be straight-chain or branched, having 1 to 3 carbon atoms and 1 to 3 OH groups, haloalkyl, which may be straight-chain or branched, having 1 to 3 carbon atoms and 1 to 3 halogen groups, and combinations thereof, preferably chlorine, bromine, fluorine, methyl, ethyl, n-propyl, iso-propyl, methoxy, ethoxy, and combinations thereof, wherein Y -< is an anion which is each independently fluoride, chloride, bromide, iodide,Sulfate, hydrogen sulfate, phosphate, hydrogen phosphate, dihydrogen phosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 C atoms or a combination thereof, and wherein the radicals D and E each independently of one another are hydrogen, halogen, hydroxyl, alkyl, which may be straight-chain or branched, having 1 to 5 carbon atoms, hydroxyalkyl, which may be straight-chain or branched, having 1 to 5 carbon atoms and 1 to 5 OH groups, phenyl, benzyl, a radical of the formula *-LR (II)< , a radical of the formula *-LC(=L)-R (III)< , a radical of the formula *-(CH 2 ) q -X, a radical of the formula *-L-(CH 2 ) q -X, or a radical of the formula *-(CH 2 ) s -L-(CH 2 ) t -X, where the radical L is each independently oxygen or sulfur, preferably oxygen, where the radicals R (II)< and R (III)< are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl,n-butyl, sec-butyl, iso-butyl, n-pentyl, phenyl or benzyl, and wherein phenyl and benzyl are each independently unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, iso-propyl, methoxy, ethoxy, and combinations thereof, the indices q, s and t each independently represent an integer from 1 to 5, wherein the indices a, c, f, g and n each independently represent an integer from 0 to 5, preferably from 1 to 4, and wherein the indices b, d and m each independently represent an integer from 1 to 5, preferably from 2 to 4, wherein the radical Ar each independently represents a radical of the general formula (25a) to (31), and wherein the radical X each independently of each other is a reactive functional group which is *-N(R (VI)< )(R (VII)< ), *-OH, *-SH, *-NCO, *-NCS,*-Si(R (VIII)< )(R (IX)< )-[O-Si(R (X)< )(R (XI)< )] p -Z or a radical with the general formula (20) to (24) means: , where the radicals R (20a)< , R (20b)< , R (20c)< , R (21a)< , R (22a)< , R (22b)< , R (22c)< , R (23a)< , R (24a)< , R (24b)< , and R (24c)< each independently of one another denote hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, iso-butyl, or n-pentyl, preferably hydrogen, methyl or ethyl, and where the indices I and k each independently denote an integer from 0 to 4, where the radicals R (VI)< , R (VII)< , R (VIII)< , R (IX)< , R (X)< and R (XI)< each independently of one another denote hydrogen, alkyl, the straight-chain or branched, having 1 to 5 carbon atoms, *-O-alkyl, which may be straight-chain or branched, having 1 to 5 carbon atoms, phenyl or benzyl, where phenyl and benzyl are each independently unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof,may be substituted, where the radical Z is each independently halogen, hydroxyl, alkoxyl having 1 to 4 carbon atoms or alkylcarboxyl having 1 to 4 carbon atoms, and where the index p is each independently an integer from 0 to 4. ,
[0069] According to the invention, at least one of the radicals R1 to R7, more preferably at least one of the radicals R1, R2, R5 or R6, more preferably at least one of the radicals R1 or R2, preferably one of the radicals R1 or R2, of the at least one phenalen-1-one compound to be used according to the invention with the general formula (1) each independently of one another is an organic radical W1, wherein the at least one organic radical W1 each independently of one another is a radical with the general formula (2) to (6) and wherein the radical Ar each independently of one another is a radical of the general formula (25a) to (31), more preferably a radical of the general formula (25a) to (28b): wherein the radicals R25, R26, R27, R28, R29, R26 a< , R26 b< , R27 a< , R27 b< , R28 a< , R28 b< , R29 a< , R29 b< , R30 a< and R30 b< each independently represent hydrogen, hydroxy, amino, alkyl, which may be straight-chain or branched, having 1 to 5 carbon atoms, *-O-alkyl, which may be straight-chain or branched, having 1 to 5 carbon atoms, phenyl or benzyl, wherein phenyl and benzyl each independently represent unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, and wherein the radical R30 each independently represents hydrogen or alkyl, which may be straight-chain or branched, having 1 to 5 carbon atoms, and wherein the radicals R33 a< and R33 b< each independently represent hydrogen, hydroxy, amino, alkyl, which may be straight-chain or branched,with 1 to 5 carbon atoms, perfluoroalkyl, which may be straight-chain or branched, with 1 to 5 carbon atoms, *-O-alkyl, which may be straight-chain or branched, with 1 to 5 carbon atoms, phenyl, benzyl or when taken together a cycloalkyl, which may be straight-chain or branched, with 4 to 9 carbon atoms, or a 9H-fluoren-9-ylidene radical, and where Y -< is an anion which, in each case independently of one another, is fluoride, chloride, bromide, iodide, sulfate, hydrogen sulfate, phosphate, hydrogen phosphate, dihydrogen phosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 C atoms or a combination thereof.
[0070] Preferably, at least one of the radicals R1 to R7, more preferably at least one of the radicals R1, R2, R5 or R6, more preferably at least one of the radicals R1 or R2, more preferably one of the radicals R1 or R2, of the at least one phenalen-1-one compound to be used according to the invention with the general formula (1) is each independently an organic radical W1, wherein the at least one organic radical W1 is each independently a radical of the general formula (40) to (67), or (72) to (98e), preferably a radical of the general formula (40) to (67) or (72) or (97): where Y -< is an anion which is each independently fluoride, chloride, bromide, iodide, sulfate, hydrogen sulfate, phosphate, hydrogen phosphate, dihydrogen phosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 carbon atoms or a combination thereof.
[0071] More preferably, the at least one phenalen-1-one compound to be used according to the invention having the general formula (1) is selected, independently of one another, from the group consisting of compounds of the formulas (100) to (127), (132) to (166) and combinations thereof, preferably from compounds of the formulas (100) to (127), (132) to (161) and combinations thereof: selected.
[0072] More preferably, a photosensitizer composition according to the invention comprises (a) at least one phenalen-1-one compound according to the invention having the general formula (1a) and (b) at least one polymeric component and / or precursor thereof.
[0073] A phenalen-1-one compound according to the invention has the general formula (1a): where the radicals R1 a< to R8 a< , which may each independently be the same or different from one another, are each hydrogen, halogen, alkyl having 1 to 12 C atoms, preferably 2 to 9 C atoms, alkylaryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, aryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, *-O-alkyl having 1 to 12 C atoms, preferably 2 to 9 C atoms, *-O-alkylaryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, *-O-aryl having 5 to 20 C atoms, preferably 6 to 9 C atoms, ether having 2 to 12 C atoms, a radical of the formula *-OC(=O)-R (Ia)< , a radical of the formula *-C(=O)-R (Ib)< , or an organic radical W1a which contains at least one reactive functional group, with the proviso that at least one of the radicals R1 a< or R2 a< , preferably one of the radicals R1 a< or R2 a< , is an organic radical W1a, where the organic radical W1a is each independently a radical of the general formula (41) to (67),or (98a) to (98e), preferably a radical of the general formula (41) to (67) and combinations thereof, means: ,
[0074] Further preferred is a phenalen-1-one compound according to the invention having the general formula (1a) from the group consisting of compounds of the formulas (101) to (127), (162) to (166) and combinations thereof, preferably of compounds of the formulas (101) to (127) and combinations thereof: selected.
[0075] In a preferred embodiment, a phenalen-1-one compound having the general formula (1) is present as a salt, wherein Y -< is an anion which, independently of one another, is fluoride, chloride, bromide, iodide, sulfate, hydrogen sulfate, phosphate, hydrogen phosphate, dihydrogen phosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 C atoms or a mixture thereof,
[0076] A suitable carboxylate anion of a carboxylic acid with 1 to 15 carbon atoms is, for example, acetate, oxalate, succinate, tartrate or a mixture thereof.
[0077] A suitable sulfonate anion of a sulfonic acid with 1 to 12 C atoms is, for example, tosylate, mesylate or a mixture thereof.
[0078] In a preferred embodiment, a photosensitizer composition according to any one of claims 1 to 3 comprises: (a) at least one phenalen-1-one compound having the general formula (1), which is a phenalen-1-one compound according to any one of claims 4 to 5, and (b) at least one polymeric component and / or precursor thereof.
[0079] In a preferred embodiment, a preferably curable photosensitizer composition according to the invention for electromagnetic radiation having a wavelength from a range of 280 to 1000 nm, more preferably from 320 to 900 nm, even more preferably from 360 to 800 nm, even more preferably from 380 to 700 nm, is at least partially, preferably completely, transparent after curing of the composition.
[0080] Preferably, the at least one phenalen-1-one compound to be used according to the invention with the general formula (1) and / or a phenalen-1-one compound according to the invention with the general formula (1a) contained in the composition is excited by electromagnetic radiation having a wavelength from a range of 280 to 1000 nm, more preferably from 320 to 900 nm, even more preferably from 360 to 800 nm, even more preferably from 380 to 700 nm.
[0081] The excited at least one phenalen-1-one compound to be used according to the invention having the general formula (1), preferably the formula (1a), can cause the formation of reactive oxygen species (ROS), whereby on the one hand radicals, for example superoxide anions, hydrogen peroxide or hydroxyl radicals, and / or on the other hand excited molecular oxygen, for example singlet oxygen, can be formed.
[0082] Since a photosensitizer composition according to the invention is at least partially, preferably completely, transparent to electromagnetic radiation having the wavelength necessary for excitation of a phenalen-1-one compound to be used according to the invention having the general formula (1) and / or a phenalen-1-one compound according to the invention having the general formula (1a), after curing, the irradiated electromagnetic radiation is only partially, preferably not, attenuated, which leads to a significant reduction in the singlet oxygen quantum yield.
[0083] A singlet oxygen quantum yield as high as possible is required for antimicrobial efficacy in the photodynamic inactivation of microorganisms on surfaces.
[0084] More preferably, a photosensitizer composition according to the invention is at least partially permeable to oxygen after curing.
[0085] Preferably, the photosensitizer composition according to the invention is, after curing, at least partially permeable both to molecular oxygen (O 2 ), which diffuses into the cured photosensitizer composition, and to singlet oxygen, which is preferably formed after irradiation of the at least one phenalen-1-one compound having the general formula (1), more preferably at least one phenalen-1-one compound having the general formula (1a), contained in the composition with electromagnetic radiation of suitable wavelength and radiation density.
[0086] The inventors have found that by using at least one phenalen-1-one compound of the general formula (1), more preferably at least one phenalen-1-one compound with the general formula (1a), in a photosensitizer composition according to the invention, it is possible to provide a surface after curing of the photosensitizer composition which, after irradiation with electromagnetic radiation of a suitable wavelength and energy density, preferably in the presence of oxygen and / or an oxygen-releasing compound, reliably inactivates microorganisms adhering to the surface.
[0087] The inventors have further found that when using at least one phenalen-1-one compound of the general formula (1), preferably at least one phenalen-1-one compound of the general formula (1a), in a photosensitizer composition according to the invention, it is possible to provide a surface after curing of the photosensitizer composition which, even upon prolonged irradiation with electromagnetic radiation of a suitable wavelength and energy density, shows essentially no, preferably no, decrease in the photodynamic activity of the surface and microorganisms adhering to the surface are reliably inactivated.
[0088] A photosensitizer composition according to the invention comprises at least one polymeric component and / or precursor thereof, wherein the at least one polymeric component and / or precursor thereof is selected from the group consisting of polymers and / or copolymers of acrylic acid and its esters, methacrylic acid and its esters, cyanoacrylic acid and its esters, acrylamide, methacrylamide, styrene, siloxanes and their esters, melamine, acrylonitrile, 1,3-butadiene, epichlorohydrin, polyols, polyisoprenes, polyethers, polyetherimides, polyvinyl acetates, polycarbonates, polyethersulfones, carboxymethylcellulose, alginate, and combinations thereof.
[0089] Preferably, the aforementioned at least one polymeric component and / or precursor thereof is a prepolymer and / or monomer, more preferably a resin. Preferably, the aforementioned at least one polymeric component and / or precursor thereof is a polyurethane resin, an epoxy resin, a silicone or silicone resin, a polyacrylic resin, polymethacrylic resin, a melamine-formaldehyde resin, phenol-formaldehyde resin, an ABS (acrylonitrile, 1,3-butadiene, styrene) resin, an alkyd resin, a polyester resin, an alkyd resin, a polyamide resin, a fluororubber resin, a vinyl ester resin, or a combination thereof. Preferably, the aforementioned at least one polymeric component and / or precursor thereof can be present as a 1-component (1K) resin or a 2-component (2K) resin.
[0090] More preferably, a photosensitizer composition according to the invention comprises at least one polymeric component and / or precursor thereof and at least one phenalen-1-one compound of the general formula (1), preferably at least one phenalen-1-one compound of the general formula (1a), wherein preferably the radical X of the at least one phenalen-1-one compound of the general formula (1), preferably at least one phenalen-1-one compound of the general formula (1a), can be matched to the at least one polymeric component and / or precursor thereof.
[0091] Preferred combinations of at least one polymeric component and / or precursor thereof and at least one radical X of at least one phenalen-1-one compound of the general formula (1) are, for example: at least one polymeric component and / or precursor thereof: Remainder X: Polyurethane resin -OH, -N(R (VI)< )(R (VII)< ), Epoxy resin -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20), (22) or (24), silicone resin, -Si(R (VIII)< )(R (IX)< )-[O-Si(R (X)< )(R (XI)< )] p -Z, a radical with the general formula (20) or (22), Polyacrylic resin a residue with the general formula (20) to (23), Polymethacrylic resin, a residue with the general formula (20) to (23), Polyacrylamide resin a residue with the general formula (20) to (23), Melamine-formaldehyde resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) or (22), Phenol-formaldehyde resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) or (22), ABS (acrylonitrile, 1,3-butadiene, styrene) resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) to (23), Alkyd resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) to (23), Polyester resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) to (23), polyamide resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) to (23), Fluororubber resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) or (22), Vinyl ester resin a residue with the general formula (20) to (23)
[0092] Preferred combinations of at least one polymeric component and / or precursor thereof and at least one radical X a< of at least one phenalen-1-one compound of the general formula (1a) are, for example: at least one polymeric component and / or precursor thereof: Remainder X a< : Polyurethane resin -OH, Epoxy resin -OH, a radical with the general formula (20), (22) or (24), silicone resin, -Si(R (VIII)< )(R (IX)< )-[O-Si(R (X)< )(R (XI)< )] p -Z, a radical with the general formula (20) or (22), Polyacrylic resin a residue with the general formula (20) to (23), Polymethacrylic resin, a residue with the general formula (20) to (23), Polyacrylamide resin a residue with the general formula (20) to (23), Melamine-formaldehyde resin, -OH, a radical with the general formula (20) or (22), Phenol-formaldehyde resin, -OH, a radical with the general formula (20) or (22), ABS (acrylonitrile, 1,3-butadiene, styrene) resin, -OH, a radical with the general formula (20) to (23), Polyester resin, -OH, a radical with the general formula (20) to (23), Alkyd resin, -OH, -N(R (VI)< )(R (VII)< ), a radical with the general formula (20) to (23), polyamide resin, -OH, a radical with the general formula (20) to (23), Fluororubber resin, -OH, a radical with the general formula (20) or (22), Vinyl ester resin Rest with the general formula (20) to (23)
[0093] A photosensitizer composition according to the invention makes it possible, after curing of the photosensitizer composition, to provide a surface which, even upon prolonged irradiation with electromagnetic radiation of suitable wavelength and energy density, exhibits essentially no, preferably no, decrease in the photodynamic activity of the surface and which reliably inactivates microorganisms adhering to the surface.
[0094] A composition according to the invention comprises at least one crosslinking agent, for example at least one polyisocyanate, a blocked isocyanate, at least one alkyl diisocyanate or cycloalkyl diisocyanate or aryl diisocyanate, at least one compound of the general formula SiZ 4 , (R XII< )SiZ 3 , (R XII< ) 2 SiZ 2 , a compound having at least two epoxide radicals, a compound having at least two acrylamide radicals, a compound having at least two acrylate radicals, a compound having at least two aldehyde radicals, a compound having at least two alcohol groups, a compound having at least two amine radicals, a divinyl sulfone, and combinations thereof, wherein the radical R XII< each independently of one another is alkyl, which may be straight-chain or branched, having 1 to 5 carbon atoms, phenyl or benzyl, preferably methyl, ethyl, n-propyl, isopropyl, phenyl or benzyl, and wherein the radical Z each independently of one another is halogen, hydroxyl,alkoxyl having 1 to 4 carbon atoms or alkylcarboxyl having 1 to 4 carbon atoms, preferably halogen or hydroxyl.
[0095] Suitable compounds with at least two alcohol groups are, for example, bisphenols, for example the commercially available bisphenols bisphenol A, bisphenol AF, bisphenol AP, bisphenol B, bisphenol BP, bisphenol C, bisphenol E, bisphenol F, bisphenol FL, bisphenol G, bisphenol M, bisphenol P, bisphenol PH, bisphenol S, bisphenol TMC, bisphenol Z and mixtures thereof, preferably bisphenol A (CAS 80-05-7), bisphenol C (CAS 79-97-0), bisphenol F (CAS 620-92-8), bisphenol S (CAS 80-09-1), bisphenol Z (CAS 843-55-0) and mixtures thereof.
[0096] More preferably, a photosensitizer composition according to the invention comprises the at least one phenalen-1-one compound having the general formula (1), preferably having the formula 1 a), covalently and / or electrostatically, preferably covalently, bound to the at least one polymeric component and / or precursor thereof.
[0097] Preferably, a photosensitizer composition according to the invention is a varnish, a glaze, an emulsion paint, a latex paint, a silicate paint, or a lime paint.
[0098] More preferably, a photosensitizer composition according to the invention is a granulate.
[0099] More preferably, a photosensitizer composition according to the invention is in the form of a coating, a self-supporting film, a fabric or a shaped article.
[0100] An article according to the invention comprising at least one cured polymer composition, wherein the cured polymer composition (a) at least one of the aforementioned phenalen-1-one compounds having the general formula (1), at least one phenalen-1-one compound according to any one of claims 4 to 5, or a combination thereof, more preferably at least one of the aforementioned phenalen-1-one compounds having the general formula (1a), and (b) at least one of the aforementioned cured polymeric components, wherein the at least one phenalen-1-one compound having the general formula (1), the at least one phenalen-1-one compound according to any one of claims 4 to 5, or a combination thereof, more preferably the at least one of the aforementioned phenalen-1-one compounds having the general formula (1a), is covalently and / or electrostatically, preferably covalently, bound to the at least one cured polymeric component.
[0101] Preferably, an article according to the invention can be obtained by coating, for example by spraying, painting, painting and / or dipping, the article with a photosensitizer composition according to the invention, which is preferably spreadable, sprayable, or flowable at the temperature of application, preferably liquid, and subsequent drying and / or curing.
[0102] For example, an article according to the invention can be obtained by laminating, covering, gluing, with a photosensitizer composition according to the invention which is in the form of a fabric or a self-supporting film.
[0103] For example, an article according to the invention can be obtained by spraying, melt blowing, extruding, or other known methods for shaping a photosensitizer composition according to the invention, which is preferably spreadable, sprayable, or flowable at the temperature of preparation, preferably liquid, and subsequent drying and / or curing.
[0104] More preferably, an article according to the invention comprises or consists of a cured polymer composition which (a) at least one phenalen-1-one compound according to any one of claims 4 to 5, and (b) at least one cured polymeric component, which is more preferably in the form of a coating, a self-supporting film, a fabric or a shaped article, wherein the at least one phenalen-1-one compound according to any one of claims 4 to 5 is covalently and / or electrostatically, preferably covalently, bonded to the at least one cured polymeric component.
[0105] The object of the present invention is further achieved by providing a non-medical use of a photosensitizer composition according to any one of claims 1 to 3 or 6 to 11 and / or a phenalen-1-one compound according to any one of claims 4 to 5 and / or an article according to any one of claims 12 to 14 for the, preferably photodynamic, inactivation of microorganisms, which are preferably selected from the group consisting of viruses, archaea, bacteria, bacterial spores, fungi, fungal spores, protozoa, algae and blood-borne parasites, and / or a biofilm thereof.
[0106] Preferably, a photosensitizer composition according to the invention or a phenalen-1-one compound according to the invention is used for photodynamic surface cleaning and / or surface coating of an object or space.
[0107] Preferably, a photosensitizer composition according to the invention or a phenalen-1-one compound according to the invention is used for the surface coating of articles, preferably medical devices, food packaging, textiles, building materials, electronic devices, furniture or hygiene articles.
[0108] Other applications include, for example, pacifiers, teats, tubes and cables, window panes, glass surfaces and / or tiles in wet rooms and / or wet cells, touchscreen elements, personal computers (PCs) and peripherals, rags, wipes, workstation pads, treatment and preparation areas in clinics and nursing homes, sanitary facilities, sanitary equipment, sausage casings, beverage containers, dishes or waste containers.
[0109] A non-medical method according to the invention for the, preferably photodynamic, inactivation of microorganisms, which preferably comprise viruses, archaea, bacteria, bacterial spores, fungi, fungal spores, protozoa, algae, blood-borne parasites or combinations thereof, and / or a biofilm thereof, comprises the following steps: (A) bringing the microorganisms and / or a biofilm thereof into contact with at least one coating which was produced by curing a photosensitizer composition according to any one of claims 1 to 3 or 6 to 11 and / or contains at least one phenalen-1-one compound according to any one of claims 4 to 5, and / or at least one article according to any one of claims 12 to 14, and (B) irradiating the microorganisms and / or a biofilm thereof and the at least one phenalen-1-one compound contained in the coating and / or the article with electromagnetic radiation of suitable wavelength and energy density.
[0110] For example, transparent, clear or translucent articles, such as pacifiers, dummies, tubes, or the like, can be produced using a photosensitizer composition according to the invention and cleaned and / or disinfected using the method according to the invention.
[0111] Further preference is given to treating objects which have a thermally limited durability, for example objects made of thermoplastics, or which are attacked by disinfectants.
[0112] For example, items that have a thermally limited shelf life cannot be sterilized sufficiently because they lose their shape or become brittle at higher temperatures.
[0113] In addition, improper and / or excessive use of disinfectants can lead to the development of resistance through the selection of robust microorganisms, for example if the active ingredient concentration and exposure time, and thus the germ-reducing effect, are too low.
[0114] In a preferred embodiment, the abovementioned alkyl radicals having 1 to 12 C atoms, more preferably 2 to 9 C atoms, are each independently selected from the group consisting of methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methylprop-1-yl, 2-methylprop-2-yl, pent-1-yl, pent-2-yl, pent-3-yl, 2-methylbut-1-yl, 2-methylbut-2-yl, 2-methylbut-3-yl, 2-methylbut-4-yl, 2,2-dimethylprop-1-yl, hex-1-yl, hex-2-yl, hex-3-yl, hept-1-yl, oct-1-yl, 2-methylpent-1-yl, 2-methylpent-2-yl, 2-methylpent-3-yl, 2-methylpent-4-yl, 2-methylpent-5-yl, 3-methylpent-1-yl, 3-methylpent-2-yl, 3-methylpent-3-yl, 2,2-dimethylbut-1-yl, 2,2-dimethylbut-3-yl, 2,2-dimethylbut-4-yl, 2,3-dimethylbut-1-yl and 2,3-dimethylbut-2-yl, n-pentyl, n-hexyl, n-heptyl and n-octyl and combinations thereof, more preferably methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl and n-octyl and combinations thereof.
[0115] In a preferred embodiment, the above-mentioned *-O-alkyl radicals having 1 to 12 C atoms, preferably 2 to 9 C atoms, are each independently selected from the group consisting of methoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, tert-butoxy and combinations thereof.
[0116] In a preferred embodiment, the aforementioned aryl radicals having 5 to 20 C atoms, more preferably 6 to 9 C atoms, are each independently selected from the group consisting of phenyl, naphthyl, anthracenyl, phenanthrenyl and pyrenyl.
[0117] In a preferred embodiment, the aforementioned *-O-aryl radicals having 5 to 20 C atoms, more preferably 6 to 9 C atoms, are each independently selected from the group consisting of *-O-phenyl, *-O-naphthyl, *-O-anthracenyl, and combinations thereof.
[0118] In a preferred embodiment, the aforementioned alkylaryl radicals having 5 to 20 C atoms, more preferably 6 to 9 C atoms, are each independently selected from the group consisting of benzyl, 2-phenyl-eth-1-yl, 3-phenyl-eth-1-yl, and combinations thereof.
[0119] In a preferred embodiment, the aforementioned *-O-alkylaryl radicals having 5 to 20 C atoms, more preferably 6 to 9 C atoms, are each independently selected from the group consisting of 1-methoxyphenyl, 1-ethoxy-2-phenyl, 1-propoxy-3-phenyl and combinations thereof.
[0120] In a further preferred embodiment, the aforementioned ether radicals each independently have 2 to 12 C atoms, more preferably 3 to 9 C atoms, more preferably 4 to 7 C atoms. In a further preferred embodiment, the aforementioned ether radicals are each independently selected from the group consisting of methoxymethyl, methoxyethyl, methoxy-n-propyl, ethoxymethyl, n-propoxymethyl, 2-ethoxyethoxymethyl, 2-(2-ethoxyethoxy)ethyl, i-propoxymethyl, tert-butyloxymethyl, dioxa-3,6-heptyl, and benzyloxymethyl. In a further preferred embodiment, the aforementioned ether radicals can be simple ether radicals, oligoether radicals, polyether radicals, or mixtures thereof.
[0121] The invention is explained below by means of figures and examples, without being limited thereto.
[0122] Fig. 1A shows the results of the log reduction of S. aureus count achieved in Example 3.1.
[0123] Fig. 1B shows the results of the log reduction of S. aureus count achieved in Example 3.2.
[0124] Fig. 2 shows the results of the log reduction of S. aureus count achieved in Example 3.3.
[0125] Fig. 3 shows the log reduction of S. aureus on the silicone surface (A - means 10 Shore without dye, A + means 10 Shore plus dye, B - means 45 Shore without dye, B + means 45 Shore plus dye).
[0126] All chemicals used were purchased from common suppliers (Thermo Fisher Scientific, Polysciences Europe GmbH, Sigma Aldrich, TCI, ABCR, Acros, Merck, and Fluka) and used without further purification. Solvents were distilled before use and dried as needed. Dry DMF was purchased from Fluka (Taufkirchen, Germany).
[0127] Thin-layer chromatography was performed on thin-layer aluminum foils coated with silica gel 60 F254 from Merck (Darmstadt, Germany). Preparative thin-layer chromatography was performed on commercially available glass plates coated with silica gel 60 (20 cm x 20 cm, Carl Roth GmbH & Co. KG, Karlsruhe, Germany). The compounds were detected by UV light (λ = 254 nm, 333 nm) and, in some cases, by the naked eye or staining with ninhydrin. Chromatographies were performed using silica gel (0.060 - 0.200) from Acros (Waltham, USA).
[0128] NMR spectra were measured on a Bruker Avance 300 spectrometer (300 MHz [1H-NMR]) (Bruker Corporation, Billerica, US).
[0129] All chemical shifts are given in δ [ppm] relative to the external standard (tetramethylsilane, TMS). The coupling constants are given in Hz. Signal characterization: s = singlet, d = doublet, t = triplet, m = multiplet, dd = doublet of doublet, br = broad. Integration determines the relative number of atoms. The DEPT method (pulse angle: 135°) was used to unambiguously determine the signals in the carbon spectra. Error limits: 0.01 ppm for 1< H NMR and 0.1 Hz for coupling constants. The solvent used is listed for each spectrum.
[0130] The IR spectra were recorded on a Biorad spectrometer Excalibur FTS 3000 (Bio-Rad Laboratories GmbH, Munich, DE).
[0131] ES-MS was measured using a ThermoQuest Finnigan TSQ 7000 spectrometer, all HR-MS was performed on a ThermoQuest Finnigan MAT 95 (both Thermo Fisher Scientific Inc, Waltham, US) spectrometer, and argon served as the ionization gas for FAB.
[0132] Melting points were determined using the Büchi SMP-20 melting point meter (Büchi Labortechnik GmbH, Essen, DE) using a glass capillary.
[0133] All UV / Vis spectra were recorded with a Varian Cary 50 Bio UV / VIS spectrometer, and fluorescence spectra were recorded with a Varian Cary Eclipse spectrometer (both Agilent Technologies, Santa Clara, US).
[0134] Solvents for absorption and emission measurements were purchased in special spectroscopic purity from Acros or Baker, and Uvasol from Merck, respectively. Millipore water (18 MΩ, Milli QPlus) was used for all measurements. Example 1: Preparation of the phenale-1-one derivatives used Overview 1: Synthesis of the phenale-1-one derivatives used
[0135]
[0136] Conditions: a ) Substituted pyridine, MeCN, 50°C, 6h; b ) Substituted dimethylamine, MeCN, RT, 24h; c ) 4N NaOH, water, toluene, tetrabutylammonium hydrogen sulfate, RT, 6h; d) Variant 1: carboxylic acid as sodium salt, Adogen ®< 464, toluene, reflux, 4h; Variant 2: carboxylic acid, DMAP, DCC, THF, 0°C → RT, 4h; e ) Substituted alcohol, toluene, 4N NaOH, tetrabutylammonium hydrogen sulfate, RT, 6h or substituted phenol, THF, PPh 3 , DEAD, 0°C → RT, 6h; f) Substituted silyl chloride, DCM or THF, triethylamine or imidazole, 0°C → RT;
[0137] Conditions: g ) carboxylic acid, THF, PPh3, DCC, 0°C → RT, 4h or carboxylic acid chloride, DCM, triethylamine, 0°C → RT, 3h; h) substituted alcohol, DCM, PPh3, DEAD, 0°C → RT, 6h;
[0138] Conditions: k ) Secondary amine in methanol, 0°C → RT, 6h; l ) Carbonyl chloride, DCM or THF, triethylamine, 0°C → RT; 1. Preparation of 2-chloromethyl-1H-phenalen-1-one
[0139] 2-Chloromethyl-1H-phenalen-1-one was prepared according to the method described in US 2014 / 039184 A1, Example 1. The NMR spectrum corresponded to the values disclosed in US 2014 / 039184 A1. 2. General provision a):
[0140] Substituted pyridine in overview 1, step a) product MW [g / mol] Sample weight [mg] formula Designation 2.1 4-Pyridinemethanol (Sigma-Aldrich) R e< = *-CH 2 OH 109,13 270 → SAPN-19a [Connection (132)] 2.2 4-Pyridineethanol (Sigma-Aldrich) R a < = *-CH 2 CH 2 OH 123,16 310 → SAPN-19b [Connection (134)] 2.3 4-Pyridinepropan-2-ol (Sigma-Aldrich) R a < = *-C(CH 3 ) 2 OH 137,18 340 → SAPN-19c [Connection (133)]
[0141] 2-Chloromethyl-1H-phenalen-1-one (115 mg, 0.5 mmol) was dissolved in acetonitrile (6 mL). The substituted pyridine (2.5 mmol) listed above was added slowly in small portions. The suspension was stirred for 3 days at room temperature in the dark.
[0142] For purification, the suspension was divided into two conical-bottom polypropylene tubes (nominal volume 15 mL, Greiner Bio-One GmbH, Frickenhausen, Germany) and precipitated to 15 mL per tube by adding diethyl ether. The product was centrifuged (60 min, 4400 rpm, 0°C), and the supernatant was discarded. The precipitate was suspended in diethyl ether. After the product had settled, the supernatant was discarded. The purification step was repeated once more, and the product was then dried. 3. Allgemeine Vorschrift b):
[0143] Substituiertes Dimethylamin in Übersicht 1, Schritt b) Produkt MW [g / mol] Einwaage [mg] Formel Bezeichnung 3.1 N,N-Dimethylallylamin (Sigma-Aldrich) R b1< = 2-Propen-1-yl R b2< , R b3< = Methyl 85,16 170 → SAPN-35a [Verbindung (135)] 3.2 1-N,N-Dimethylamino-2-propin (Sigma-Aldrich) R b1< = 2-Propin-1-yl R b2< , R b3< = Methyl 83,13 166 → SAPN-35a [Verbindung (136)] 3.3 N-(4-Vinylbenzyl)-N,N-dimethylamin (Thermo Fisher Scientific) R b1< = 4-Vinylphen-1-yl R b2< , R b3< = Methyl 161,24 322 → SAPN-36 [Verbindung (137)] 3.4 2-(N,N-Dimethylamino)-ethylmethacrylat (Sigma-Aldrich) R b1< = Eth-1-ylmethacrylat R b2< , R b3< = Methyl 157,21 314 → SAPN-37a [Verbindung (138)] 3.5 N-[2-(N,N-Dimethylamino)-ethyl]-methacrylamid (Polysciences Europe GmbH) R b1< = Eth-1-ylmethacrylamid R b2< , R b3< = Methyl 156,22 312 → SAPN-37b [Verbindung (139)] 3.6 (N,N-Dimethyl-3-aminopropyl)-trimethoxysilan (Sigma-Aldrich) R b1< = 3-(Trimethoxysilyl)-prop-1-yl R b2< , R b3< = Methyl 207,34 414 → SA-PN-38 [Verbindung (140)] 3.7I 1-N-Bocethylendiamin (Sigma-Aldrich) R b1< = 2-N-Boc-ethylenamin-1-yl R b2< , R b3< = H 160,2 320 → SA-PN-25c-boc 3.8 2-N-Boc-aminoethyl-1-N,N-dimethylamine R b1 < = 2-N-Boc-ethyleneamine-1-yl R b2 < , R b3 < = methyl 198,2 396 → SA-PN-25a-boc 3.9 1,1-N,N-(2-N-Boc-aminoethyl)-N-methylamine R b1< , R b2< = 2-N-Boc-ethyleneamine-1-yl R b3< = methyl 327,2 654 → SA-PN-34a-boc 3.10 R b1< = *-(CH 2 ) 2 O(CH 2 ) 2 OH R b2< , R b3< = CH3 133,19 400 → SA-PN-11 [Connection (142)] 3.11 R b1< = *-(CH 2 ) 2 O[(CH 2 ) 2 O] 2 HR b2< , R b3< = CH 3 177,25 530 → SA-PN-12 [Connection (143)] 3.12 N,N-dimethylaminoethanol R b1< = *-(CH 2 ) 2 OH R b2< , R b3< = CH 3 89,14 270 → SA-PN-09 [Connection (141)]
[0144] 2-Chloromethyl-1H-phenalen-1-one (115 mg, 0.5 mmol) was dissolved in acetonitrile (6 mL). The substituted dimethylamine (2 mmol) listed above was added slowly in small portions. The suspension was stirred for 48 h at room temperature in the dark.
[0145] For purification, the suspension was divided into two conical-bottom polypropylene tubes (nominal volume 15 ml, Greiner Bio-One GmbH) and precipitated to 15 mL per tube by adding diethyl ether. The product was centrifuged (60 min, 4400 rpm, 0°C), and the supernatant was discarded. The precipitate was suspended in diethyl ether. After the product had settled, the supernatant was discarded. The purification step was repeated once more, and the product was then dried. 4. Procedure c): Preparation of 2-hydroxymethyl-1H-phenalen-1-one [Name: PNOH, compound (100)]
[0146]
[0147] 2-Chloromethyl-1H-phenalen-1-one (230 mg, 1 mmol) was dissolved in 20 mL of toluene. Aqueous sodium hydroxide (4N, 5 mL) and the phase-transfer catalyst tetrabutylammonium hydrogen sulfate (100 mg) were added. The reaction mixture was stirred vigorously at room temperature for 6 h. A yellow-brown precipitate formed. The precipitate was filtered off and washed with water (4 times, 20 mL), toluene, and petroleum ether (1 time, 20 mL each). The product was dried in air to constant weight. 5. General provision d):
[0148] Carboxylic acid in overview 1, step d) product MW [g / mol] Sample weight [mg] formula Designation 5.1 Acrylic acid (Sigma-Aldrich) R d< = *-CH=CH 2 72,06 72 → PN-AMO-07a [Connection (110)] 5.2 Methacrylic acid (Sigma-Aldrich) R d< = *-C(CH 3 )=CH 2 87,09 87 → PN-AMO-07b [Connection (112)] 5.3 4-Vinylbenzoic acid (Sigma-Aldrich) R d< = 4-Vinylphen-1-yl 148,16 148 → PN-AMO-08 [Connection (107)] Variant 1:
[0149] The above-mentioned carboxylic acids (1 mmol) were each neutralized with an equimolar amount of sodium hydroxide and the resulting sodium salt of the carboxylic acid was isolated by freeze-drying.
[0150] 2-Chloromethyl-1H-phenalen-1-one (115 mg, 0.5 mmol) was dissolved in toluene (3 mL). The sodium salt of the above-mentioned carboxylic acid, hydroquinone (11 mg, 0.1 mmol), and Adogen®< 464 (200 mg) were added, and the reaction mixture was refluxed for 4 h with vigorous stirring. After cooling to room temperature, the mixture was diluted with toluene (20 mL) and extracted with water (30 mL). The aqueous phase was extracted twice with ethyl acetate (20 mL). The organic phases were combined, washed with water (50 mL), separated, and dried over magnesium sulfate.
[0151] After filtration and concentration under reduced pressure, the crude product was purified by flash chromatography (DCM / PE 2:1). Variant 2:
[0152] Compound (100) (65 mg, 0.3 mmol) was dissolved in dry THF (1 mL). The above-mentioned carboxylic acid, hydroquinone (11 mg, 0.1 mmol), DMAP (61 mg, 0.5 mmol), and DCC (103 mg, 0.5 mmol) were added at 2-5°C. The reaction mixture was stirred vigorously for 4 h at RT. It was diluted with ethyl acetate (20 mL) and extracted with water (30 mL). The aqueous phase was extracted twice with ethyl acetate (20 mL). The organic phases were combined, washed with water (50 mL), separated, and dried over magnesium sulfate.
[0153] After filtration and concentration under reduced pressure, the crude product was purified by flash chromatography (DCM / PE 2:1). 6. General provision e):
[0154] Substituted alcohol in overview 1, step e) product MW [g / mol] Sample weight [mg] formula Designation 6.1 Allyl alcohol (Sigma-Aldrich) R e< = 2-propen-1-yl 58,08 58 → PN-AMO-04a [Connection (114)] 6.2 Propargyl alcohol (Sigma-Aldrich) R e< = 2-propyn-1-yl 56,06 56 → PN-AMO-04b [Connection (118)] 6.3 4-Vinylphenol (Sigma-Aldrich) R a < = 4-vinylphen-1-yl 120,15 120 → PN-AMO-06 [Connection (108)] 6.4 2-Allyloxyethanol (Sigma-Aldrich) R a < = 2-allyloxyeth-1-yl 102,13 102 → PN-AMO-05 [Connection (119)] 6.5 Glycerol (Sigma-Aldrich) R e< = 2,3-dihydroxyprop-1-yl 92,09 92 → PN-AMO-10 [Connection (103)] 6.6 4-Hydroxybenzyl alcohol (Sigma-Aldrich) R e< = 4-(Hydroxymethyl)phen-1-yl 124,14 124 → PN-AMO-02b [Connection (105)] 6.7 4-Hydroxy-3-methoxy-benzyl alcohol (Sigma-Aldrich) R e < = 4-(Hydroxymethyl)-2-methoxy-phen-1-yl 154,17 154 → PN-AMO-04a [Connection (104)]
[0155] 2-Chloromethyl-1H-phenalen-1-one (115 mg, 0.5 mmol) was initially dissolved in toluene (4 mL). The substituted alcohol (1 mmol) indicated above, hydroquinone (11 mg, 0.1 mmol), and tetrabutylammonium hydrogen sulfate (100 mg) were added. 2 mL of 4N aqueous sodium hydroxide solution was added to the vigorously stirring solution at 2-5°C. The ice bath was removed, and the reaction mixture was stirred vigorously for a further 6 h. It was diluted with 30 mL of DCM and extracted several times with water (4 times, 20 mL each).
[0156] The organic phase was separated and dried over magnesium sulfate. After filtration and concentration under reduced pressure, the crude product was purified by flash chromatography (DCM / PE 2:1). 7. General rule f):
[0157] Substituted silyl chloride in overview 1, step f) product MW [g / mol] Sample weight [mg] formula Designation 7.1 Triethoxychlorosilane (Sigma-Aldrich) 198,72 76 → PN-AMO-14a [Connection (123)] R f1< , R f2< , R f3< = ethoxy 7.2 Allyldimethylchlorosilane (Sigma-Aldrich) 134,68 54 → PN-AMO-14b [Connection (124)] R f1< = 2-Propen-1-yl R f2< , R f3< = Methyl
[0158] 2-Hydroxymethyl-1H-phenalen-1-one (70 mg, 0.3 mmol) was placed under nitrogen in a 10 mL round-bottom flask with a septum, together with imidazole (30 mg, 0.4 mmol) in dry DCM (3 mL). The substituted silyl chloride (0.4 mmol) in 2 mL of dry DCM (as described above) was slowly added dropwise via the septum at approximately 0°C using a syringe. The ice bath was removed, and the reaction mixture was stirred overnight at room temperature. It was diluted with 30 mL of DCM and extracted several times with water (4 times, 20 mL each). The organic phase was separated and dried over magnesium sulfate. After filtration and concentration under reduced pressure, the crude product was purified by flash chromatography (DCM / PE 2:1). 8. General provision g):
[0159] Carboxylic acid in overview 1, step g) product MW [g / mol] Sample weight [mg] formula Designation 8.1 Acrylic acid 72,06 53 → PN-AMO-12a [Connection (109)] R g< = *-CH=CH 2 8.2 Methacrylic acid 87,09 62 → PN-AMO-12b [Connection (111)] R g< = *-C(CH 3 )=CH 2 8.3 4-vinylbenzoic acid 148,16 88 → PN-AMO-12c [Connection (106)] R g< = 4-vinylphen-1-yl
[0160] 3-Hydroxyphenalen-1-one (Sigma-Aldrich) (100 mg, 0.5 mmol) was placed under nitrogen in a 10 mL round-bottom flask with a septum, along with triphenylphosphine (50 mg, 1 mmol), and the above-mentioned carboxylic acid (0.6 mmol) in dry THF (5 mL). DCC (103 mg, 0.5 mmol) in dry THF (1 mL) was slowly added dropwise via the septum at approximately 0°C using a syringe. After stirring in an ice bath for 2 h, another portion of DCC (103 mg, 0.5 mmol) in dry THF (1 mL) was added dropwise. The reaction mixture was stirred in a thawing ice bath, then at room temperature for 6 h. The THF was evaporated, the residue was taken up in 30 mL of DCM, and extracted several times with water (4 times, 20 mL).
[0161] The organic phase was separated and dried over magnesium sulfate. After filtration and concentration under reduced pressure, the crude product was purified by flash chromatography (DCM / PE 2:1). 9. General provision h):
[0162] substituted alcohol in overview 1, step h) product MW [g / mol] Sample weight [mg] formula Designation 9.1 Allyl alcohol 58,08 23 → PN-AMO-11a [Connection (113)] R h< = 2-Propen-1-yl 9.2 Propargyl alcohol 56,06 22 → PN-AMO-11b [Connection (117)] R h< = 2-Propyn-1-yl 9.3 Glycidol (Sigma-Aldrich) 74,08 30 → PN-AMO-13 [Connection (115)] R h< = 2,3-epoxy-prop-1-yl 9.4 Bis(2-hydroxyethyl)ether (Thermo Fisher Scientific) 106,12 42 → PN-AMO-03a [Connection (102)] R h < = *-(CH 2 ) 2 O(CH 2 ) 2 OH 9.5 1,3-propanediol (Sigma-Aldrich) 76,10 31 → PN-AMO-03b [Connection (101)] R h< = *-(CH 2 ) 2 OH 9.6l 3-Boc-aminopropan-1-ol (Sigma-Aldrich) 175,2 70 → SAPN-32-boc R h< = *-(CH 2 ) 2 NHBoc
[0163] 3-Hydroxyphenalen-1-one (60 mg, 0.3 mmol) was placed under nitrogen in a 10 mL round-bottom flask with a septum, along with triphenylphosphine (30 mg, 0.6 mmol) in DCM (3 mL), and the substituted alcohol (0.4 mmol). DEAD in toluene (40%, 0.2 mL, 0.4 mmol) was slowly added dropwise via a syringe at approximately 0°C via the septum. The reaction mixture was stirred in a thawing ice bath, then at room temperature for 6 h. It was diluted with 30 mL DCM and extracted several times with water (4 times, 20 mL). The organic phase was separated and dried over magnesium sulfate. After filtration and concentration under reduced pressure, the crude product was purified by flash chromatography (DCM / PE 2:1). 10. Regulation k): Preparation of 2-(N-methylamino)methyl-1H-phenalen-1-one hydrochloride [Designation: SAPN-02c, Compound 158]
[0164]
[0165] 2-Chloromethyl-1H-phenalen-1-one (113 mg, 0.5 mmol) in methanol (10 mL) was added dropwise to an ice-cold solution of the amine in methanol (10 mL, 5 M) over 2 h. After 1 h of vigorous stirring at room temperature, the solvent, along with the excess amine, was removed under a stream of nitrogen. The residue was dissolved in as little DCM / ethanol 4:1 as possible and precipitated by adding diethyl ether. The product was centrifuged (60 min, 4400 rpm, 0°C), and the supernatant was discarded. The precipitate was suspended in diethyl ether and centrifuged again. The purification step was repeated once more, and the product was then dried. 11. General Rule I):
[0166] Carbonyl chloride in Overview 1, Step I) product MW [g / mol] Sample weight [mg] formula Designation 11.1 Acrylic acid chloride (Merck-Millipore) 90,5 36 → PN-AMO-07a [Connection (126)] R k< = Methyl R l< = 2-ethen-1-yl 11.2 Methacrylic acid chloride 104,53 41 → PN-AMO-07b [Connection (126)] R k< = Methyl R l< = 1-methyl-2-ethen-1-yl
[0167] 2-(N-Methylamino)methyl-1H-phenalen-1-one hydrochloride (80 mg, 0.3 mmol) was dissolved with triethylamine (100 mg, 1 mmol) in DCM (3 mL) and stirred in an ice bath under exclusion of moisture. The corresponding carboxylic acid chloride (0.4 mmol) in DCM (0.5 mL) was added dropwise. The reaction mixture was stirred in a thawing ice bath, then at room temperature for 4 h. It was diluted with 30 mL of DCM and extracted several times with water (4 times, 20 mL). The organic phase was separated and dried over magnesium sulfate. After filtration and concentration under reduced pressure, the crude product was purified by flash chromatography. 12. Synthesis of compound (127) [Name: PN-AMO-01]
[0168]
[0169] 2-Chloromethyl-1H-phenalen-1-one (230 mg, 1.0 mmol) in acetonitrile (20 mL) was added dropwise to a solution of 3-aminopropanol (1.5 mL, 20 mmol) in acetonitrile (50 mL) over 30 min. After stirring at room temperature overnight, triethylamine (2.02 g, 2.66 mL, 20 mmol) was added, and the solution was stirred in an ice bath. Acetic anhydride (3.06 g, 2.83 mL, 30 mmol) was added dropwise at approximately 0°C. The reaction mixture was stirred at room temperature for 2 h, then heated to 50°C for 1 h. All volatiles were removed under reduced pressure.
[0170] The product was purified by column chromatography using dichloromethane / ethanol 20:1, yielding 261 mg of yellow syrup. This material was dissolved in methanol (2 mL). Aqueous sodium hydroxide solution (1 M, 0.5 mL) was added, and the mixture was stirred overnight at room temperature. The alcohol was evaporated, and the remaining solution was diluted with water (10 mL). The product was extracted with dichloromethane (2 x 10 mL). The organic phases were dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The product was a yellowish, greasy solid (215 mg, 69%, 0.69 mmol). 13. Deprotection of the Boc group
[0171] product protected phenalenone derivative formula Designation 13.1 (from Synthesis 3.7) → SA-PN-25c [Connection (150)] 13.2 (from Synthesis 3.8) → SA-PN-25b [Connection (159)] 13.3 (from Synthesis 3.9) → SA-P N-34 b [Connection (160)] 13.4 (from Synthesis 9.6) → SAPN-32 [Connection (161)]
[0172] The corresponding tert-butyloxycarbonyl (Boc-protected) phenalenone derivative was initially dissolved in dichloromethane (3 mL per 100 mg). A saturated solution of hydrogen chloride in diethyl ether (0.5 mL per mmol of Boc group) was added dropwise. The mixture was stirred for 3 h under exclusion of moisture. The product was precipitated by adding 30 mL of diethyl ether. The precipitate was centrifuged and thoroughly washed with diethyl ether. The product was dried under reduced pressure.
[0173] The calculated molecular mass (MW) and molecular formula (MF) as well as the data of the measured mass spectra (MS) and 1 H-NMR spectra are given below for the prepared compounds. Substance No. structure Molecular mass (MW) / Molecular formula (MF) Mass spectrum (MS) NMR 2.1 SAPN-19a MW: 302.3 + 35.45 = 337.75 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 302.1 (100%, M+) 1< H-NMR (300 MHz, DMSO-d6): δ [ppm] = 9,18 (d, J = 6,8 Hz, 2H), 8,54 - 8,45 (m, 2H), 8,42 (s, 1H), 8,35 (d, J = 7,8 Hz, 1H), 8,15 (d, J = 6,4 Hz, 1H), 8,04 (d, J = 6,7 Hz, 2H), 7,91 (t, J = 7,7 Hz, 1H), 7,80 (dd, J = 8,2 & 7,2 Hz, 1H), 6,17 (t, J = 5,4 Hz, 1H), 5,79 (s, 2H), 4,80 (d, J = 4,5 Hz, 2H). MF: C 20 H 16 NO 2 Cl 2.2 SAPN-19c MW: 330.4 + 35.45 = 365.85 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 330.1 (100%, M+) 1< H-NMR (300 MHz, DMSO-d6): δ [ppm] = 9,18 (d, J = 6,8 Hz, 2H), 8,52 (dd, J = 8,9, 7,7 Hz, 2H), 8,45 (s, 1H), 8,36 (d, J = 8,1 Hz, 1H), 8,22 - 8,13 (m, 3H), 7,93 (t, J = 7,7 Hz, 1H), 7,82 (dd, J = 8,1 & 7,3 Hz, 1H), 5,91 (s, 1H), 5,78 (s, 2H), 1,49 (s, 6H). MF: C 22 H 20 NO 2 Cl 2.3 SAPN-19b MW: 316.4 + 35.45 = 351.85 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 316.1 (100%, M+) 1< H-NMR (300 MHz, DMSO-d6): δ [ppm] = 9,11 (d, J = 6,6 Hz, 2H), 8,60 - 8,45 (m, 2H), 8,46 - 8,31 (m, 2H), 8,17 (d, J = 6,9 Hz, 1H), 8,02 (d, J = 6,6 Hz, 2H), 7,93 (t, J = 7,7 Hz, 1H), 7,87 - 7,72 (m, 1H), 5,75 (s, 2H), 4,95 (s, 1H), 3,75 (t, J = 5,9 Hz, 2H), 3,01 (t, J = 6,0 Hz, 2H). MF: C 21 H 18 NO 2 Cl 3.1 SAPN-35a MW: 278.38 + 35.45 = 313.83 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 278.2 (100%, M+) 1< H-NMR (300 MHz, MeOD): δ [ppm] = 8,66 (dd, J = 7,4 & 1,1 Hz, 1H), 8,49 - 8,37 (m, 2H), 8,36 - 8,24 (m, 1H), 8,18 - 8,06 (m, 1H), 7,91 (t, J = 7,8 Hz, 1H), 7,77 (dd, J = 8,2 & 7,2 Hz, 1H), 5,87 - 5,69 (m, 2H), 4,56 (s, 2H), 4,10 (d, J = 7,3 Hz, 2H), 3,11 (s, 6H). MF: C 19 H 20 NOCl 3.2 SAPN-35b MW: 276.36 + 35.45 = 311.81 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 276.1 (100%, M+) 1< H-NMR (300 MHz, MeOD): δ [ppm] = 8,66 (dd, J = 7,4 & 1,1 Hz, 1H), 8,51 - 8,37 (m, 2H), 8,30 (d, J = 8,3 Hz, 1H), 8,12 (d, J = 6,5 Hz, 1H), 7,91 (t, J = 7,8 Hz, 1H), 7,77 (dd, J = 8,2 & 7,2 Hz, 1H), 4,67 (s, 2H), 4,47 (s, 2H), 3,64 (m, 1H), 3,25 (s, 6H). MF: C 19 H 18 NOCl 3.3 SAPN-36 MW: 354.48 + 35.45 = 389.93 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 354.2 (100%, M+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,92 (s, 1H), 8,57 (dd, J = 7,4 & 0,9 Hz, 1H), 8,25 (d, J = 7,3 Hz, 1H), 8,12 (d, J = 7,7 Hz, 2H), 7,79 (t, J = 7,7 Hz, 1H), 7,66 (m, 3H), 7,57 (m, 2H), 7,43 (d, J = 8,1 Hz, 2H), 7,57 (m, 2H), 6,68 (m, 1H), 5,80 (d, J = 16,8 Hz, 1H), 5,33 (d, J = 10,9 Hz, 1H), 5,15 (s, 2H), 5,03 (s, 2H), 3,19 (s, 6H). MF: C 25 H 24 NOCl 3.4 SAPN-37a MW: 350.44 + 35.45 = 385.89 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 350.2 (100%, M+) 1< H-NMR (300 MHz, MeOD): δ [ppm] = 8,58 (dd, J = 7,4, 1,1 Hz, 1H), 8,52 - 8,32 (m, 2H), 8,25 (dd, J = 8,3 & 0,7 Hz, 1H), 8,18 - 8,03 (m, 1H), 7,93 - 7,78 (m, 1H), 7,76 - 7,63 (m, 1H), 6,19 (m, 1H), 5,72 (m, 1H), 4,89 (m, 2H), 4,67 (m, 2H), 3,98 - 3,76 (m, 2H), 3,26 (s, 6H), 1,97 (s, 3H). MF: C 22 H 24 NO 3 Cl 3.5 SAPN-37b MW: 349.46 + 35.45 = 384.91 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 349.2 (100%, M+) Not measured MF: C 22 H 25 N 2 O 2 Cl 3.6 SA-PN-38 MW: 400.57 + 35.45 = 436.02 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 358.1 (100%, (M-3Me)+) 1< H-NMR (300 MHz, DMSO-d6): δ [ppm] = 8,81 - 7,29 (m, 7H), 5,67 (m, 1H), 4,55 (s, 2H), 3,64 (m, 2H), 3,45 - 2,98 (m, 15H), 2,03 (m, 2H), 0,77 (m, 2H). MF: C 22 H 30 NO 4 SiCl 3.7 SA-PN-25c-boc MW: 352.44 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 353.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,64 (dd, J = 7,4 & 1,0 Hz, 1H), 8,21 (d, J = 8,2 Hz, 1H), 8,03 (d, J = 8,2 Hz, 1H), 7,92 (s, 1H), 7,79 (dd, J = 16,7 & 7,4 Hz, 2H), 7,65 - 7,57 (m, 1H), 5,40 (s, 1H), 3,98 (s, 2H), 3,41 (d, J = 5,3 Hz, 2H), 3,03 - 2,95 (m, 2H), 1,42 (s, 9H). MF: C 21 H 24 N 2 O 3 3.8 SA-PN-25a MW: 381.50 + 35.45 = 416.95 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 381.0 (100%, M+) 1< H-NMR (300 MHz, DMSO-d6): δ [ppm] = 8,66 - 8,47 (m, 2H), 8,39 (d, J = 8,1 Hz, 1H), 8,18 (d, J = 6,8 Hz, 1H), 7,96 (t, J = 7,7 Hz, 1H), 7,83 (dd, J = 8,1 & 7,3 Hz, 1H), 7,27 (t, J = 5,1 Hz, 1H), 4,57 (s, 2H), 3,55 - 3,40 (m, 4H), 3,13 (s, 6H), 1,39 (s, 9H). MF: C 23 H 29 N 2 O 3 Cl 3.9 SA-PN-34a MW: 510.66 + 35.45 = 546.12 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 510.3 (100%, M+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,89 (s, 1H), 8,58 (d, J = 7,3 Hz, 1H), 8,31 - 8,02 (m, 3H), 7,78 (t, J = 7,7 Hz, 1H), 7,66 (t, J = 7,7 Hz, 1H), 6,53 (s, 2H), 4,82 (s, 2H), 3,98 - 3,58 (m, 8H), 3,22 (s, 3H), 1,39 (s, 18H). MF: C 29 H 40 N 3 O 5 Cl 3.10 SA-PN-11 MW: 326.4 + 35.45 = 361.85 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): e / z (%) = 326.2 (100, M +< ); 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,69 (s, 1H), 8,48 - 8,34 (m, 1H), 8,17 - 7,91 (m, 3H), 7,65 (t, J = 7,6 Hz, 1H), 7,56 (t, J = 7,7 Hz, 1H), 5,03 - 4,78 (bs, 1H), 4,81 (s, 2H), 4,06 (m, 2H), 3,84 (m, 2H), 3,69 (m, 2H), 3,63 (m, 2H), 3,30 (s, 6H). MF: C 20 H 24 NO 3 Cl 3.11 SA-PN-12 MW: 370.5 + 35.45 = 405.95 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): e / z (%) = 370.2 (100, M +< ); 1< H-NMR (300 MHz, DMSO): δ [ppm] = 8,65 - 8,45 (m, 3H), 8,39 (d, J = 8,0 Hz, 1H), 8,17 (d, J = 6,5 Hz, 1H), 7,96 (t, J = 7,7 Hz, 1H), 7,83 (dd, J = 8,2 & 7,2 Hz, 1H), 4,60 (s, 2H), 3,97 (s, 2H), 3,75 - 3,41 (m, 13H), 3,14 (s, 6H). MF: C 22 H 28 NO 4 Cl 3.12 SA-PN-09 MW: 282.4 + 35.45 = 317.85 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): e / z (%) = 282.1 (100, M +< ); 1< H-NMR (300 MHz, DMSO-d6): δ[ppm] = 8,58 - 8,54 (dd, J = 1,0 & 7,3 Hz, 1H), 8,55 - 8,50 (dd, J = 1,2 & 7,4 Hz, 1H), 8,52 (s, 1H), 8,37 (dd, J = 1,0 & 7,8 Hz, 1H), 8,18 (dd, J = 0,9 Hz, J = 7,1 Hz, 1H), 7,95 (t, J = 7,7 Hz, 1H), 7,84 - 7,78 (m, 1H), 5,62 (t, J = 5,1 Hz, 1H), 4,61 (s, 2H), 3,99 - 3,88 (m, 2H), 3,59 - 3,51 (m, 2H), 3,15 (s,6H). MF: C 18 H 20 NO 2 Cl 4 PNOH MW: 210.33 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 211.1 (100%, MH+), 193.1 (64%, MH+ - H 2 O) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,66 (dd, J = 7,4 & 1,2 Hz, 1H), 8,22 (dd, J = 8,1, 1,1 Hz, 1H), 8,01 (m, 2H), 7,89 - 7,74 (m, 2H), 7,62 (dd, J = 8,2 & 7,1 Hz, 1H), 4,82 (d, J = 1,4 Hz, 2H). MF: C 14 H 10 NO 2 5.1 PN-AMO-07a MW: 264.28 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 265.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,67 (d, J = 7,4 Hz, 1H), 8,23 (d, J = 8,0 Hz, 1H), 8,03 (d, J = 8,4 Hz, 2H), 7,87 - 7,76 (m, 2H), 7,65 - 7,59 (m, 1H), 6,64 (d, J = 16,6 Hz, 1H), 6.35 (dd, J = 16,6, 10,1 Hz, 1H), 6,18 (d, J = 10,1 Hz, 1H), 4,83 (s, 2H). MF: C 17 H 12 O 3 5.2 PN-AMO-07b MW: 278.31 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 279.1 (100%, MH+) Not measured MF: C 18 H 14 O 3 5.3 PN-AMO-08 MW: 340.38 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 341.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,69 (d, J = 7,4 Hz, 1H), 8,25 (d, J = 8,1 Hz, 1H), 8,22 (d, J = 8,4 Hz, 2H), 8,05 (d, J = 8,4 Hz, 2H), 7,89 - 7,74 (m, 2H), 7,67 - 7,62 (m, 1H), 7,58 (d, J = 8,3 Hz, 2H), 6,90 - 6,73 (m, 2H), 5,94 (d, J = 17,5 Hz, 1H), 5,48 (d, J = 10,8 Hz, 1H), 4,85 (s, 1H). MF: C 23 H 16 O 3 6.1 PN-AMO-04a MW: 250.30 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 193.1 (52%, MH+ -C3H6O), 251.1 (100%, MH+), 273.1 (13%, MNa+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,63 (d, J = 7,4 Hz, 1H), 8,19 (d, J = 8,1 Hz, 1H), 7,99 (d, J = 8,3 Hz, 1H), 7,85 (m, 1H), 7,75 (m, 2H), 7,58 (t, J = 7,7 Hz, 1H), 6,06 (m, 1H), 5,40 (dd, J = 17,2 & 1,6 Hz, 1H), 5,26 (dd, J = 10,4 & 1,1 Hz, 1H), 4,61 (s, 2H), 4,20 (d, J = 5,6 Hz, 2H). MF: C 17 H 14 O 2 6.2 PN-AMO-04b MW: 248.28 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 249.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,66 (dd, J = 7,4, 1,1 Hz, 1H), 8,22 (dd, J = 8,0, 0,9 Hz, 1H), 8,02 (d, J = 8,1 Hz, 1H), 7,87 (t, J = 1,4 Hz, 1H), 7,79 (t, J = 7,7 Hz, 2H), 7,61 (dd, J = 8,2, 7,2 Hz, 1H), 4,71 (d, J = 1,5 Hz, 2H), 4,37 (d, J = 2,4 Hz, 2H), 2,51 (t, J = 2,4 Hz, 1H). MF: C 17 H 12 O 2 6.3 PN-AMO-06 MW: 312.37 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 313.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,70 (d, J = 6,4 Hz, 1H), 8,25 (d, J = 8,1 Hz, 1H), 8,04 (d, J = 8,1 Hz, 1H), 7,95 (s, 1H), 7,86 - 7,78 (m, 2H), 7,66 - 7,58 (m, 1H), 7,38 (d, J = 8,7 Hz, 2H), 7,03 (d, J = 8,7 Hz, 2H), 6,67 (dd, J = 17,6, 10,9 Hz, 1H), 5,63 (d, J = 17,6 Hz, 1H), 5,20 (d, J = 1,5 Hz, 2H), 5,14 (d, J = 11,0 Hz, 1H). MF: C 22 H 16 O 2 6.4 PN-AMO-05 MW: 294.35 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 193.1 (27%, MH+ -C5H10O2), 295.1 (100%, MH+), 317.1 (10%, MNa+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,63 (dd, J = 7,4 & 1,1 Hz, 1H), 8,19 (dd, J = 8,1 & 0,9 Hz, 1H), 7,99 (d, J = 8,1 Hz, 1H), 7,89 (t, J = 1,5 Hz, 1H), 7,76 (t, J = 7,6 Hz, (ddd, J = 17,2 J = & 1H), 5,94 (m, 1H), 5,32 2H), 7,58 (dd, & 3,2 & 1,6 Hz, 1H), 5,26 - 5,16 (m, 1H), 4,66 (d, J = 1,5 Hz, 2H), 4,09 (dt, J = 5,6 & 1,3 Hz, 2H), 3,83 (m, 2H), 3,72 (m, 2H). MF: C 19 H 18 O 3 6.5 PN-AMO-10 MW: 284.31 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 285.1 (100%, MH+), 263.1 (29%, MH+ - H 2 O) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,62 (d, J = 7,6 Hz, 1H), 8,20 (d, J = 8,1 Hz, 1H), 7,97 (d, J = 8,2 Hz, 1H), 7,87 (s, 1H), 7,76 (t, J = 7,5 Hz, 2H), 7,56 (t, J = 7,6 Hz, 1H), 4,61 (s, 2H), 4,12 - 3,56 (m, 7H). MF: C 17 H 16 O 4 6.6 PN-AMO-02b MW: 316.36 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 317.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,69 (d, J = 7,4 Hz, 1H), 8,23 (d, J = 8,1 Hz, 1H), 7,98 (d, J = 8,1 Hz, 1H), 7,93 (s, 1H), 7,78 - 7,73 (m, 2H), 7,62 - 7,51 (m, 1H), 7,01 (d, J = 7,8 Hz, 2H), 6,78 (d, J = 7,8 Hz, 2H), 5,26 (m, 2H), 4,46 (s, 2H). MF: C 21 H 16 O 3 6.7 PN-AMO-02a MW: 346.39 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 347.1 (100%, MH+), 369.1 (9%, MNa+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,67 (dd, J = 7,3 & 0,9 Hz, 1H), 8,21 (d, J = 8,0 Hz, 1H), 8,01 (d, J = 8,2 Hz, 1H), 7,94 (s, 1H), 7,78 (dd, J = 10,8 & 4,4 Hz, 2H), 7,65 - 7,52 (m, 1H), 6,97 - 6,89 (m, 2H), 6,84 (dd, J = 8,2 & 1,7 Hz, 1H), 5,24 (d, J = 1,3 Hz, 2H), 4,63 (s, 2H), 3,95 (s, 3H). MF: C 22 H 18 O 4 7.1 PN-AMO-14a MW: 372.50 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 373.1 (13%, MH+), 286.1 (100%, (M -3 C 2 H 5 )+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,67 (d, J = 7,4 Hz, 1H), 8,22 (d, J = 7,5 Hz, 1H), 8,03 (d, J = 8,6 Hz, 2H), 7,90 - 7,74 (m, 2H), 7,67 - 7,57 (m, 1H), 4,82 (s, 2H), 3,76 - 3,69 (m, 6H), 1,26 (d, J = 7,0 Hz, 9H). MF: C20H24O5Si 7.2 PN-AMO-14b MW: 308.46 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 309.1 (26%, MH+), 193.1 (100%, (M -H 2 O - C 5 H 11 Si)+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,67 (d, J = 7,4 Hz, 1H), 8,22 (d, J = 8,2 Hz, 1H), 8,03 (d, J = 8,4 Hz, 2H), 7,90 - 7,74 (m, 2H), 7,68 - 7,57 (m, 1H), 4,98 (dd, J = 28,1, 14,7 Hz, 1H), 4,83 (s, 2H), 1,72 (dt, J = 6,4, 1,6 Hz, 1H), 0,51 (d, J = 5,2 Hz, 1 H), 0,23 - 0,07 (m, 6H). MF: C19H20O2Si 8.1 PN-AMO-12a MW: 250.26 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 251.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,70 (d, J = 7,3 Hz, 1H), 8,57 (d, J = 6,6 Hz, 1H), 8,27 (d, J = 8,0 Hz, 1H), 8,19 (d, J = 7,8 Hz, 1H), 8,11 (s, 1H), 7,79 (dt, J = 21,7, 7,8 Hz, 2H), 6,70 (dd, J = 17,3, 1,1 Hz, 1H), 6,41 (dd, J = 17,3 & 10,4 Hz, 1H), 6,11 (dd, J = 10,4 & 1,1 Hz, 1H). MF: C 16 H 10 O 3 8.2 PN-AMO-12b MW: 264.28 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 265.1 (100%, MH+) Not measured MF: C 17 H 12 O 3 8.3 PN-AMO-12c MW: 326.36 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 327.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,55 (d, J = 7,3 Hz, 1H), 8,19 (d, J = 8,3 Hz, 2H), 8,12 (d, J = 8,0 Hz, 1H), 8,00 (d, J = 8,2 Hz, 1H), 7,91 (d, J = 7,2 Hz, 1H), 7,69 (t, J = 7,7 Hz, 1H), 7,61 - 7,48 (m, 3H), 6,91 - 6,60 (m, 2H), 5,92 (d, J = 17,6 Hz, 1H), 5,45 (d, J = 10,9 Hz, 1H). MF: C 22 H 14 O 3 9.1 PN-AMO-11a MW: 236.27 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 237.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,59 (dd, J = 7,3, 1,1 Hz, 1H), 8,31 (dd, J = 7,3, 0,9 Hz, 1H), 8,22 - 8,14 (m, 1H), 8,08 (d, J = 7,5 Hz, 1H), 7,78 - 7,57 (m, 2H), 6,23 - 6,08 (m, 2H), 5,55 (dd, J = 17,3, 1,4 Hz, 1H), 5,42 (dd, J = 10,5, 1,2 Hz, 1H), 4,73 (d, J = 5,4 Hz, 2H). MF: C 16 H 12 O 2 9.2 PN-AMO-11b MW: 234.26 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 235.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,56 (d, J = 7,2 Hz, 1H), 8,47 (d, J = 7,3 Hz, 1H), 8,20 (d, J = 8,0 Hz, 1H), 8,10 (d, J = 8,1 Hz, 1H), 7,81 - 7,63 (m, 2H), 7,57 (s, 1H), 4,35 - 4,10 (m, 2H), 2,63 (s, 1H). MF: C 16 H 10 O 2 9.3 PN-AMO-13 MW: 252.27 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 253.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,59 (dd, J = 7,1 & 0,9 Hz, 1H), 8,29 (m, 2H), 8,17 (d, J = 7,6 Hz, 1H), 7,47 (t, J = 7,8 Hz, 1H), 7,31 (t, J = 7,8 Hz, 1H), 7,16 (m, 1H), 4,18 (dd, J = 11,4 & 4,6 Hz, 1H), 3,93 (dd, J = 11,2 & 5,8 Hz, 1H), 3,31 (m, 1H), 2,88 (m, 1H), 2,69 (m, 1H). MF: C 16 H 12 O 3 9.4 PN-AMO-03a MW: 284.31 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 285.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,26 (dd, J = 7,2 & 0,8 Hz, 1H), 7,94 - 7,74 (m, 2H), 7,66 (d, J = 7,9 Hz, 1H), 7,43 (t, J = 7,7 Hz, 1H), 7,23 (t, J = 7,8 Hz, 1H), 5,79 (s, 1H), 4,13 - 3,97 (m, 2H), 3,88 - 3,79 (m, 2H), 3,77 - 3,69 (m, 2H), 3,68 - 3,51 (m, 3H). MF: C 17 H 16 O 4 9.5 PN-AMO-03b MW: 254.29 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 255.1 (100%, MH+) H-NMR (300 MHz, MeOD): δ [ppm] = 8,66 - 8,58 (m, 1H), 8,45 (m, 2H), 8,27 (m, 1H), 7,96 - 7,72 (m, 3H), 3,22 (t, J = 7,1 Hz, 2H), 2,47 (m, 2H), 1,81 (m, 2H). MF: C 16 H 14 O 3 9.6 SAPN-32boc MW: 353.42 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 354.2 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,56 (dd, J = 7,3 & 1,0 Hz, 1H), 8,22 (d, J = 7,2 Hz, 1H), 8,19 - 8,11 (m, 1H), 8,05 (d, J = 7,9 Hz, 1H), 7,72 (t, J = 7,7 Hz, 1H), 7,67 - 7,55 (m, 1H), 6,13 (s, 1H), 4,81 (s, 1H), 4,22 (t, J = 5,9 Hz, 2H), 3,43 (s, 2H), 2,14 (p, J = 6,3 Hz, 2H), 1,45 (s, 9H). MF: C 21 H 23 NO 4 10 SAPN-02c MW: 223.28 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 223.1 (100%, M+) H-NMR (300 MHz, MeOD): δ [ppm] = 8,68 (dd, J = 7,4 & 1,0 Hz, 1H), 8,51 - 8,38 (m, 1H), 8,27 (d, J = 7,9 Hz, 1H), 8,20 (s, 1H), 8,07 (d, J = 7,0 Hz, 1H), 7,91 (t, J = 7,8 Hz, 1H), 7,76 (dd, J = 8,2 & 7,2 Hz, 1H), 4,21 (s, 2H), 2,79 (s, 3H). MF: C 15 H 13 NO 11.1 PN-AMO-09a MW: 291.35 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 292.1 (100%, MH+) 1H NMR (300 MHz, CDCI3): δ [ppm] = 8,72 - 8,59 (m, 1H), 8,30 - 8,16 (m, 1H), 8,02 (dd, J = 14,3 & 8,2 Hz, 1H), 7,85 - 7,72 (m, 2H), 7,60 (m, 1H), 7,47 (s, 1H), 6,62 (m, 1H), 6,41 (m, 1H), 5,70 (m, 1H), 4,72 - 4,60 (m, 2H), 3,20 (d, J = 27,8 Hz, 3H). MF: C 19 H 17 NO 2 11.2 PN-AMO-09b MW: 277.33 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 278.1 (100%, MH+) Not measured MF: C 18 H 15 NO 3 12 PN-AMO-01 MW: 309.37 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 310.1 (100%, MH+) 1< H-NMR (300 MHz, CDCl 3 ): δ [ppm] = 8,69 (dd, J = 1,2 & 7,4 Hz, 1H), 8,26 (dd, J = 1,0 & 8,1 Hz, 1H), 8,08 (dd, J = 0,6 & 8,2 Hz, 1H), 7,78 - 7,90 (m, 2H), 7,62 (dd, J = 7,0 & 1,2 Hz, 1H), 7,51 (s, 1H), 4,65 (s, 2H), 3,83 (bs, 1H), 3,66 (t, J = 5,6 Hz, 2H), 3,59 (t, J = 5,6 Hz, 2H), 2,16 (s, 3H), 1,78 (m, 2H). MF: C 19 H 19 NO 3 13.1 SA-PN-25c MW: 252.32 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 253.1 (100%, MH+) H-NMR (300 MHz, MeOD): δ [ppm] = 8,71 (dd, J = 7,4 & 1,0 Hz, 1H), 8,46 (d, J = 8,1 Hz, 1H), 8,29 (t, J = 3,9 Hz, 2H), 8,10 (d, J = 7,1 Hz, 1H), 7,92 (t, J = 7,8 Hz, 1H), 7,77 (dd, J = 8,2 & 7,2 Hz, 1H), 4,33 (s, 2H), 3,46 (m, 4H). MF: C 16 H 16 N 2 O 13.2 SA-PN-25b MW: 281.38 + 35.45 = 316.83 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 281.1 (100%, M+) 1< H-NMR (300 MHz, DMSO-d6): δ [ppm] = 8,68 (s, 3H), 8,57 (dd, J = 10,0 & 6,5 Hz, 3H), 8,40 (d, J = 8,3 Hz, 1H), 8,22 (d, J = 7,0 Hz, 1H), 7,97 (t, J = 7,7 Hz, 1H), 7,91 - 7,76 (m, 1H), 4,62 (s, 2H), 3,77 - 3,65 (m, 2H), 3,43 (m, 2H), 3,20 (s, 6H). MF: C 18 H 21 N 2 OCl 13.3 SA-PN-34b MW: 310.42 + 35.45 = 345.87 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 310.1 (100%, M+) H-NMR (300 MHz, MeOD): δ [ppm] = 8,74 (dd, J = 7,5 & 0,9 Hz, 1H), 8,47 (d, J = 8,0 Hz, 1H), 8,31 (t, J = 3,8 Hz, 2H), 8,12 (d, J = 7,2 Hz, 1H), 7,93 (t, J = 7,6 Hz, 1H), 7,79 (dd, J = 8,2 & 7,4 Hz, 1H), 4,35 (s, 2H), 3,58 - 3,35 (m, 8H). MF: C 19 H 24 N 3 O 13.4 SAPN-32 MW: 253.30 g / mol MS (ESI-MS, CH 2 Cl 2 / MeOH + 10 mmol NH 4 OAc): m / z = 254.1 (100%, MH+) H-NMR (300 MHz, MeOD): δ [ppm] = 8,62 - 8,50 (m, 1H), 8,42 (m, 2H), 8,26 (m, 1H), 7,98 - 7,70 (m, 3H), 3,05 (t, J = 7,0 Hz, 2H), 2,88 - 2,78 (m, 2H), 1,86 (dd, J = 9,5 & 3,6 Hz, 2H). MF: C 16 H 15 NO 2 Example 2: Production of antimicrobial surface coatings
[0174] The photosensitizers prepared in Example 1 were subsequently tested in various coating systems. 1) 2 components (2K) polyurethane varnish, solvent-based
[0175] The respective photosensitizer (0.06 mmol) was dissolved in 100 mL of a clear base coat (polyisocyanate-crosslinkable, hydroxyl-containing acrylic resin, 20% in xylene / n-butyl acetate). The crosslinker (hexamethylene diisocyanate (HDI)-containing polymer, 20% in xylene / n-butyl acetate, "Desmodur®< N75" from Covestro AG, Leverkusen, Germany) was mixed with the base coat in a ratio of 5:1 (v / v). The viscous, pale yellow solution was applied to various degreased surfaces using a spray gun. Tested surfaces included PMMA, PVC, glass, aluminum, stainless steel, and wood. After drying for 4 h at room temperature, full curing was achieved by heating to 60°C for 30 min.
[0176] The following photosensitizers were processed using this method:
[0177] Result:Transparent, pale yellow, homogeneous coating; layer thickness between 20 and 40 µm 2) 1 component (1K) polyurethane paint, Water-based
[0178] The respective photosensitizer (0.05 mmol) was dissolved in the water-based varnish (100 mL, acrylic polyurethane dispersion, fatty acid modified, 20% in water). The mixture was stirred vigorously for 30 min at room temperature. The varnish was evenly applied with a brush to i) an untreated wooden board, ii) PMMA sheets, or iii) PVC sheets. Alternatively, the varnish was evenly applied with a spray gun from a distance of approximately 30 cm. The coating was allowed to air dry and cured overnight at room temperature.
[0179] The following photosensitizers were processed using this method:
[0180] Result: Transparent, matte, pale yellow, homogeneous coating; layer thickness approx. 50 µm. 3) 2K epoxy resins Composition of the base resin (typical technical products):
[0181] Recipe I (resin with reactive thinner): Bisphenol A-epichlorohydrin resin with an average molecular weight of < 700 g / mol (25-50%) C12-C14 Aliphatic glycidyl ether (25-50%) Alkyl glycidyl ethers (5-25%) Recipe II (resin with reactive thinner): Bisphenol A-epichlorohydrin resin with an average molecular weight of < 700 g / mol (60-80%) 1,4-Bis(2,3-epoxypropox)butane (20-40%) Recipe III (resin with reactive thinner): Bisphenol A-epichlorohydrin resin with an average molecular weight of < 700 g / mol (75-90%) Hexanediol diglycidyl ether (10-25%) Recipe IV (resin with reactive thinner): Bisphenol A-epichlorohydrin resin with an average molecular weight of < 700 g / mol (50-90%) Bisphenol F epoxy resin (25 - 50%) C12-C14 Aliphatic glycidyl ether (10-20%) 1,4-bis(2,3-epoxypropoxy)butane (10-20%) Composition of the hardener (typical technical products):
[0182] Recipe I (normal hardener): Isophoronediamine (aminomethyl-3,5,5-trimethyl-cyclohexylamine) (10-25%) Benzyl alcohol (25-50%) 2,2,4-Trimethylhexane-1,6-diamine (3-10%) Recipe II (normal hardener): Isophoronediamine (aminomethyl-3,5,5-trimethylcyclohexylamine) (44%) Xylidenediamine (10%) Trimethylhexamethylenediamine (5%) Salicylic acid (1%) Polyethylenamine (10%) Benzyl alcohol (30%) Recipe III (fast hardener): Diaminocyclohexane (18%) Pentamethylenediamine (25%) Salicylic acid (2%) Polyethylenamine (20%) Benzyl alcohol (35%) Optional with accelerator / catalyst: N-Benzyldimethylamine (BDMA) and / or N,N,N,N-Tetramethyl-1.3 butanediamine (TMBDA) and / or 2-Methylimidazole (2MI) Variant a)
[0183] The respective photosensitizer (0.05 mmol) was dissolved in 25 mL of the clear hardener (Formulation I or II). 75 mL of the base resin (Formulation II, III, or IV) was mixed with the hardener. The viscous, pale yellow solution was sprayed onto a degreased surface of i) PMMA or ii) PVC.
[0184] Alternatively, the mixture was applied evenly to untreated wood with a brush in several repetitions to create an antimicrobial sealant. After curing for 12 hours at room temperature, it was post-cured by heating to 40°C for 6 hours.
[0185] The following photosensitizers were processed using this method:
[0186] Result: Transparent, pale yellow, homogeneous coating; layer thickness between 20 and 40 µm Variant b)
[0187] The respective photosensitizer (0.05 mmol) was dissolved in 30 mL of the clear hardener (Formulation II or III). 70 mL of the base resin (Formulation I) was mixed with the hardener. A shallow stainless steel tray was evenly coated with release wax. Within the tray, i) a glass fiber mat, ii) a piece of CFRP fabric, or iii) a piece of aramid fabric (each 20 x 20 cm²) was evenly saturated with the resin mixture using a brush, allowing the fabric to completely absorb the mixture. After curing for 24 h at room temperature, post-curing was performed by slowly heating to 60°C and holding for 30 min.
[0188] The following photosensitizers were processed using this method:
[0189] Result: Tough, limitedly flexible fiber mat; the dye's own color is not visible Variant c)
[0190] The respective photosensitizer (0.05 mmol) was dissolved in 70 mL of the base resin (Formulation II, III, or IV). 30 mL of the hardener (Formulation III) was added. The viscous, pale yellow solution was sprayed onto a degreased surface of i) PMMA or ii) roughened glass.
[0191] Alternatively, the mixture was evenly applied to untreated wood with a brush in several repetitions to create an antimicrobial sealant. After curing for 6 hours at room temperature, it was post-cured by heating to 40°C for 3 hours. The following representatives were processed using this method:
[0192] Result: Transparent, pale yellow, homogeneous coating; layer thickness between 20 and 40 µm, when using a brush > 50 µm 4) Room temperature vulcanizing 1 component (RTV-1) silicone,
[0193] Typical composition of the silicone (technical product from Wacker) Polydimethylsiloxanediol and polydimethylsiloxane in a mixture with silicon dioxide (filler) and triacetoxymethylsilane (crosslinker, <5%) Variant a)
[0194] Clear sanitary silicone (1K, room temperature curing, acetic acid curing, 5.0 g) was dissolved in hexane (10 mL). A solution of the respective photosensitizer (0.012 mmol) in dried dichloromethane (20 mL) was added. The slightly cloudy, pale yellow, viscous solution was evenly applied to i) a degreased glass plate, ii) a degreased PMMA plate, iii) a ceramic plate, or iv) a polyester film. After approximately 15 minutes at room temperature, the coating had begun to dry, and approximately 10 minutes later, the first skin formation occurred. After 6 hours at room temperature, the approximately 0.1 mm thick layer was fully cured.
[0195] Result:Transparent, matt, pale yellow, homogeneous, rubber-like coating Variant b)
[0196] The respective photosensitizer (0.02 mmol) was dissolved in dried ethyl acetate (100 mL). Clear sanitary silicone (1K, room temperature curing, acetic acid curing, 8.0 g) was added, and the solution was stirred until homogeneous. The slightly cloudy, pale yellow solution was evenly applied to i) a clay plate, ii) a ceramic tile, iii) a degreased PE plate, or iii) an aluminum plate using a spray gun. After approximately 20 minutes at room temperature, the coating had partially dried, and approximately 10 minutes later, the first skin formation occurred. After 6 hours at room temperature, the approximately 0.1 mm thick layer was fully cured.
[0197] Result: Transparent, matt, pale yellow, homogeneous, rubber-like coating Variant c)
[0198] The finely powdered photosensitizer (0.012 mmol) was stirred into clear sanitary silicone (1K, room temperature curing, acetic acid curing, 5.0 g) in a SpeedMixer™< DAC 600 (Hauschild Engineering, Germany) at room temperature until a macroscopically homogeneous paste was obtained. The pale yellow, viscous mass was evenly applied with a disposable syringe to i) a tile joint or ii) used to bond two perpendicular glass plates. After approximately 30 minutes at room temperature, the silicone had begun to dry, and approximately 20 minutes later, the first skin formed. After 6 hours at room temperature, the layer was fully cured.
[0199] The following photosensitizers were processed into pale yellow, rubbery silicone sealants according to the three variants:
[0200] Result: Transparent, matt, pale yellow, homogeneous, rubber-like joint filling 5) Room temperature vulcanizing 2 components (RTV-2) silicone
[0201] Typical composition of the silicone (technical product from Wacker): Component A) Vinyl-containing oligomeric silane / vinylsilane and component B) polydimethylsiloxane mixed with silicon dioxide (filler) and auxiliaries and platinum catalyst
[0202] The base polymer (A) was mixed with the crosslinker (B) 9:1.
[0203] The finely powdered photosensitizer (0.05 mmol) was stirred into 90 g of the base polymer (A) at room temperature until a macroscopically homogeneous paste was obtained. The pale yellow, viscous mass was mixed with the crosslinker (B) in a ratio of 9:1 and evenly applied (50 mL per m²) using a flat spatula to i) a polyester film, ii) a ceramic tile, a degreased glass plate, iv) a degreased PE plate, or v) an aluminum plate.
[0204] After approximately 30 minutes at room temperature, initial skin formation occurred. After 8 hours at room temperature, the layer was fully cured.
[0205] The following photosensitizers were processed into silicone coatings:
[0206] Result: Transparent, matt, pale yellow, homogeneous, rubber-like coating 6) Polyacrylate 1K
[0207] The finely powdered photosensitizer (0.05 mmol) was dissolved in 100 mL of ethyl methacrylate (dry conditions). Camphorquinone (1.7 mg, 0.01 mmol) and methyl 4-dimethylaminobenzoate (0.9 mg, 0.005 mmol, amine accelerator) were added, and the mixture was stirred for 15 min in the dark. The solution was stable for weeks when refrigerated in the dark.
[0208] The solution was applied to i) wood with a brush or ii) a filter paper was soaked or iii) evenly sprayed onto a degreased PMMA plate.
[0209] In the second step, the specimens were cured for 30 seconds using a polymerization light (LED Bluephase; ivociarVivadent AG at 650 mW / cm²). After preparation, the specimens were stored in a drying cabinet at 37 °C for 24 hours to complete polymerization. The following photosensitizers were used in the experiments:
[0210] Result: The result is i) a transparent, polymeric seal, ii) a semi-flexible, pale yellow platelet or iii) a transparent, pale yellow, lacquer-like coating. 7) Polyacrylate 2K Variant a)
[0211] The respective photosensitizer (0.05 mmol) was dissolved in 100 mL of methyl methacrylate (methyl methacrylate, MMA, Sigma Aldrich) (solution A). tert-Butyl peroxybenzoate (Peroxan PB, 0.5 g) was dissolved in THF (2 mL) (solution B). Solution B was added to solution A, and the mixture was heated for 15 min at 90°C in a water bath. The slightly viscous solution was sprayed onto i) a degreased PMMA plate or ii) a degreased glass plate or iii) pinewood and evenly distributed with a brush (50 mL per m²). To fully cure the acrylic coating, the substrate was stored in a drying cabinet at 60°C for 24 hours. A pale yellow, clear plastic coating or polymeric sealant for the wood was obtained.
[0212] Result: Transparent, homogeneous, lacquer-like coating; in i) and ii) the inherent yellow color of the layer was faintly visible, in iii) the inherent color was indistinguishable from the substrate Variant b)
[0213] The respective photosensitizer (0.05 mmol) was dissolved in 100 mL of methyl methacrylate (methyl methacrylate, MMA, Sigma Aldrich) (solution A). Benzoyl peroxide (0.5 g) was dissolved in THF (2 mL) (solution B). Solution B was added to solution A, and the mixture was heated for 20 min at 80°C in a water bath. The mixture was applied to i) approximately 6 mm thick cotton fleece, or ii) an approximately 6 mm thick felt mat, or iii) a piece of aramid fabric (each 20 x 20 cm²) using a brush to evenly impregnate the mixture so that the fabric could completely absorb the mixture.
[0214] To fully cure the acrylic, the fiber mats were dried at 60°C for 12 hours. A yellowish, solid plate was obtained. The following photosensitizers were used:
[0215] Result: Tough, limitedly flexible fiber mat; the dye's own color is only slightly visible in i) 8) Polyacrylamide
[0216] A 40% solution of acrylamide / bis-acrylamide (37.5:1) in water (2.5 mL) was mixed with Tris buffer (3.75 mL, 1M, pH 8.8) and propylene glycol (0.6 mL). The respective photosensitizer (0.005 mmol) in distilled water (3.0 mL) was added. The solution was degassed with a vacuum pump for 5 minutes (5-10 mbar) and then treated with TEMED (10 µL). Finally, 0.05 mL of ammonium persulfate (10% in water) was added to the solution with stirring.
[0217] i) A 3 mm thin cassette (plates previously cleaned with 70% alcohol) was filled with the mixture and carefully overlaid with isopropanol. After 30 minutes of polymerization at room temperature, the gel was solid, and the supernatant could be poured off. After removing the chamber plates, a flexible, thick, pale yellow film was obtained. Alternatively, ii) the mixture was evenly applied to a nonwoven fabric.
[0218] During polymerization, the material was covered with cling film. After 30 minutes of polymerization at room temperature, the gel was solid, and the film was carefully removed. A gel-like, yellowish coating was obtained.
[0219] The following photosensitizers were polymerized in this way:
[0220] Result: i) Rubbery, slightly cloudy, pale yellow mat; ii) Transparent, matt, pale yellow, homogeneous, rubbery coating 9) Cyanoacrylate Variant a)
[0221] The respective photosensitizer (0.01 mmol) was dissolved in 100 mL of dichloromethane (dried over calcium chloride). 0.2 g of commercially available cyanoacrylate (Loctite, Henkel AG & Co. KGaA, Düsseldorf, Germany) was added to 1 g of the solution (dry conditions). The mixture was sprayed evenly onto a) a degreased glass plate or b) dry spruce wood. At room temperature and an ambient humidity between 20 and 70%, the layer cured completely within 20 minutes. Variant b)
[0222] The respective photosensitizer (0.01 mmol) was dissolved in 100 mL of dried methyl ethyl ketone. Commercially available cyanoacrylate (Loctite) was mixed with 10 g of the solution in a ratio of 1:5 (w / w). The solution was evenly applied to a substrate cleaned with isopropanol, e.g., i) glass, ii) PE, or iii) melamine board. After evaporation of the solvent, the coating was cured by exposure to atmospheric moisture (approx. 15 min, humidity between 20 and 70%).
[0223] The following photosensitizers were processed according to the respective variant: Variant a Variant a Variant b Variant b Variant b Variant b
[0224] Result: Transparent, slightly cloudy, pale yellow, homogeneous coating; layer thickness between 20 and 40 µm 10) Polystyrene
[0225] The respective photosensitizer (0.01 mmol) was dissolved in 20 mL of freshly distilled polystyrene (Sigma Aldrich) (solution A). Benzoyl peroxide (0.5 g) was dissolved in THF (2 mL) (solution B). Solution B was added to solution A, and the mixture was heated for 20 min at 80°C in a water bath. 5 to 6 mL of the mixture was evenly coated with a brush onto i) a clean, untreated chipboard, ii) a degreased PMMA plate, or iii) a degreased glass plate (each 20 x 20 cm²). The support was allowed to dry for 12 hours at 60°C for complete curing. A yellowish solid plate was obtained. The following photosensitizers were used: 11) Carboxymethylcellulose coatings
[0226] The respective photosensitizer (0.05 mmol) was dissolved in 100 ml of water along with finely ground carboxymethylcellulose (4.0 g, Akzo Nobel). 5 to 6 mL of the clear, slightly viscous solution was evenly coated with a brush onto i) a clean, untreated chipboard or ii) a degreased PMMA plate (each 20 x 20 cm²).
[0227] Alternatively, iii) a cotton fleece (20 x 20 cm 2 ) was evenly saturated with a brush, allowing the fabric to completely absorb the mixture. The carrier was allowed to dry for 3 hours at room temperature to cure. The following photosensitizers were used:
[0228] Result: i) transparent, polymeric seal with no discernible intrinsic color; ii) transparent, slightly cloudy, pale yellow, homogeneous coating; iii) tough, limitedly flexible fiber mat; intrinsic color of the photosensitizer was barely discernible 12) Alginate coatings
[0229] Sodium hydroxide (850 mg, 21.25 mmol) was dissolved in 95 mL of distilled water. 5 g of alginic acid (Sigma Aldrich) was added to the warm solution (approx. 35°C) and stirred for 3 h. A slightly viscous, clear solution was obtained. A stock solution of the respective photosensitizer (5 mL, 12 mmol / L) was added dropwise with stirring. The yellow, slightly viscous solution was used to soak i) a piece of paper or ii) a piece of cotton fleece or iii) a cellulose rag / compress (each 20 x 20 cm²). The excess solution was allowed to drain off. The moist support was quickly immersed in a 1% calcium chloride solution. The material was allowed to drain thoroughly, then gently blotted and dried in air at room temperature for 3 hours.
[0230] The following photosensitizers were processed:
[0231] Result: Tough, limitedly flexible fiber mat or piece of paper; the inherent color of the photosensitizer was barely visible Example 3: Testing the effectiveness of antimicrobial surface coatings 1.) Preparation of the sample carriers
[0232] The following photosensitizer was used for the following experiments Absorption maximum 360 - 420 nm Molar extinction coefficient 9800 L mol -1< cm -1<
[0233] The photosensitizer was dissolved in the respective coating system and applied to various rectangular sample carriers (width: 4 cm, length: 4 cm, thickness: 3 mm) made of PVC or PMMA and dried. After the coating had dried, a defined amount of bacteria of the species Staphylococcus aureus ATCC 25923 applied to the surface.
[0234] For this purpose, an overnight culture of S. aureus in 5 mL Mueller Hinton Boullion (Carl Roth GmbH + Co. KG, Karlsruhe, DE) was inoculated with a single colony from an agar plate and incubated at 37 °C and 180 rpm on a shaker for 18–20 h. On the day of the experiment, 1 mL of the overnight culture was centrifuged (Hettich Centrifuge Universal 320 R (Andreas Hettich GmbH & Co.KG, Tuttlingen, DE); swing-bucket rotor 1494; 10 min, 3000 rpm, RT). The supernatant was discarded, and the pellet was resuspended in 1 mL Milli-Q water, which was commercially available from Merck (KGaA, Darmstadt, DE) (designation "Milli-Q Integral Purified Water (Type 1)").
[0235] After determining the optical density at 600 nm (spectrometer "Speccord 50 plus", Analytik Jena), the resuspended bacteria were diluted with Milli-Q water to a cell count of 10 5 < bacteria / mL. 100 µL of the diluted solution was pipetted onto the sample carrier (drop size approximately 1 cm 2 < ).
[0236] Thus, approximately 10,000 bacteria per cm² were found on the surface of each sample carrier. The sample carrier was then dried in air under a sterile workbench in the dark for approximately 2 hours until no more water was visible on the surface. 2.) Irradiation and quantitative determination of colony-forming units (CFU) / mL
[0237] The respective sample carriers were irradiated with monochrome light at a wavelength of 405 nm using an LED module (5 × 5 cm test field, homogeneously illuminated; high-power LEDs) or with room light (Osram Lumilux Cool White, color temperature 4000 K) at the intensities and irradiation times specified below. Immediately after irradiation, the bacteria were wiped from the surface of the respective sample carrier using a sterile swab and resuspended in 1 mL of Mueller-Hinton broth.
[0238] The sample was then serially diluted (1:10 dilution steps: 180 + 20 µL; up to dilution step 10 -5< ).
[0239] From each dilution level (100 to 10 -5< ), three 20 µL portions of broth were pipetted onto a Mueller-Hinton agar plate (Carl Roth GmbH + Co. KG) and distributed. The agar plates were then incubated at 37°C above sea level.
[0240] The next day, the countable colonies of all dilution levels of an experiment were counted and the CFU / mL were calculated.
[0241] Dilution levels that showed a bacterial lawn or no colonies at all were designated "∞" or "0" and were not included in the calculation of CFU / mL.
[0242] The log 10 kill rate was then calculated from the CFU / mL value. The reference control (= 100% of the number of bacteria used) served as the reference point in each experiment.
[0243] One experiment was composed as follows: Coated sample carrier: without photosensitizer, not irradiated ("reference control") Coated sample carrier: with photosensitizer, not irradiated ("dark control") Coated sample carrier: without photosensitizer and irradiated ("light control") Coated sample carrier: with photosensitizer and irradiated ("sample") 3.) Coating systems and irradiation parameters used 3.1.) 2K polyurethane varnish, solvent butyl acetate / Xylene from Example 2.1
[0244] Coated material: PMMA, 3 mm thickness, 4 x 4 cm Drying time approx. 1 hour Drying temperature 15 - 30 °C Application with a spray gun Used concentration of the phosphosensitizer: 200 µm (61.55 mg / l) Irradiation conditions:
[0245] Experiment No. Irradiation source Irradiation intensity Irradiation duration 3.1.1 LED module (405 nm) 10 mW / cm 2 2 minutes 3.1.2 LED module (405 nm) 20 mW / cm 2 2 minutes 3.1.3 LED module (405 nm) 0.7 mW / cm 2 0 to 150 min 3.2.) 1K polyurethane varnish, water-based from example 2.2
[0246] Coated material: PVC, 3 mm thickness, 4 x 4 cm Drying time approx. 2 hours Drying temperature 15 - 30 °C Relative humidity for the drying time 30 - 70 % Application with a spray gun Used concentration of the phosphosensitizer: 200 µm (61.55 mg / l) Irradiation conditions:
[0247] Experiment No. Irradiation source Irradiation intensity Irradiation duration 3.2.1 LED module (405 nm) 10 mW / cm 2 10 minutes 3.3) Room temperature vulcanizing 2-component (RTV-2) silicone from Example 2.5
[0248] Coated material: PVC, 3 mm thick, 4 x 4 cm Drying time approx. 2 hours Drying temperature 15 - 30 °C Relative humidity during drying time 30 - 70 % Application with a spray gun Used Phosensitizer concentration: 200 µm (61.55 mg / l) Two silicone hardness grades (so-called "Shores"): A = 10 Shore; B = 45 Shore Irradiation conditions: Experiment No. Irradiation source Irradiation intensity Irradiation duration 3.3.1 LED module (405 nm) 10 mW / cm 2 5 minutes 3.3.2 LED module (405 nm) 10 mW / cm 2 10 minutes 4.) Results and evaluation 4.1.) 2K polyurethane varnish (solvent: butyl acetate / Xylene) from Example 2.1
[0249] In an initial study with the 2K coating system, high intensities of 10 and 20 mW / cm 2 were used to test the effectiveness of the photosensitizer SAPN-19c against S. aureus. The results are presented in Fig. 1A shown.
[0250] Fig. 1Ashows the mean values of S. aureus reduction on the 2K paint surface from three independent experiments. Irradiation was carried out at 10 and 20 mW / cm² and for 2 minutes (corresponding to an energy density of 1.2 and 2.4 J / cm², respectively).
[0251] Fig. 1A shows that the 2K coating system achieves a log 10 reduction of 1.8 (average of 3 independent experiments) after just 2 minutes of irradiation at a light intensity of 10 mW / cm 2 . Increasing the light intensity to 20 mW / cm 2 leads to a more effective kill of 2.7 log 10 levels.
[0252] The effectiveness was then determined at low intensities of 0.7 mW / cm 2<. The results are shown in Fig. 1B shown.
[0253] Fig. 1B shows the mean values of the reduction of S. aureus on the 2K paint surface (colorless solvent-based 2K paint on transparent PMMA sample carrier) from two independent tests.
[0254] Irradiation was carried out at 0.7 mW / cm 2 for up to 150 minutes (corresponding to an energy density of up to 6.3 J / cm 2 ). The mean value of the reference control (no light, no catalyst) was 3.2 x 10 4 bacteria per mL. The light and dark control was carried out only at 150 minutes.
[0255] The decrease in colony forming units relative to a non-irradiated sample (0 min) was measured at intervals, according to the Fig. 1b At the specified time points (5 min., 10 min., 20 min., 30 min., 40 min., 60 min., 90 min., 120 min. and 150 min.), two coated sample carriers were removed from the irradiation. The results from two independent experiments are shown in Fig. 1B shown.
[0256] The mean value of the reference control (no light, no catalyst) was 3.2 × 10 4 bacteria per mL. The light and dark control was performed only at 150 minutes.
[0257] Figure 1Bshows that after just 20 minutes the 2K paint system achieves a killing of S. aureus by 1.9 log10 levels.
[0258] The 2K coating system showed biological efficacy against S. aureus when irradiated with an artificial light source, both at high intensities and low irradiation times ( Fig. 1A ), as well as at low intensities and longer irradiation times ( Fig. 1B ). 4.2.) 1K polyurethane varnish, water-based from example 2.2
[0259] A first test with a high intensity (10 mW / cm 2< ) and a long irradiation time (10 minutes) showed the effectiveness of the 1K paint system.
[0260] The results are in Fig. 2 shown.
[0261] Fig. 2 shows the mean reduction values of S. aureus on the 1K paint surface from three independent experiments. Irradiation was carried out at 10 mW / cm² and for 10 minutes (corresponding to an energy density of 6 J / cm²).
[0262] Experiments with the 1K coating system clearly demonstrate that effective killing of S. aureus on the coated surface only occurs with the interaction of light and the photodynamic catalyst. Three independent experiments show an average killing efficiency of 3.0 Log 10 at an energy density of 6 J / cm².
[0263] The light control in the experiments showed an average reduction of 1.2 log 10 steps, which is probably due to the dark sample carrier. 3.3) Room temperature vulcanizing 2-component (RTV-2) silicone from Example 2.5
[0264] A first test with a high intensity (10 mW / cm 2< ) and an irradiation time of 5 minutes and 10 minutes respectively demonstrated the effectiveness of the RTV-2 silicone system.
[0265] The results are in Fig. 3 shown, where the mean value of 3 experiments is shown Fig. 3shows the log reduction of S. aureus on the silicone surface (A - means 10 Shore without dye, A + means 10 Shore plus dye, B - means 45 Shore without dye, B + means 45 Shore plus dye). 4.3) Summary
[0266] In the tested coating systems (2K PUR coating system; 1K PUR coating system, RTV-2 silicone), the photosensitizer SAPN-19c used showed biological effectiveness against S. aureus on the painted surface coating.
[0267] Higher light intensities and / or longer irradiation times produce more singlet oxygen, resulting in faster and more effective killing of microorganisms on the surface.
[0268] The concentration of 200 µM (61.55 mg / L) used in both coating systems was not visible on stained surfaces. Furthermore, the coating achieved a reduction of 3 log10 levels (= 99.9%) of the applied bacteria at a light intensity of 6 J / cm². Example 4. Testing the phototoxic effect of a coated surface under office lighting (neon tube)
[0269] In a subsequent test, the 2K coating system was irradiated with ambient light. For this purpose, the photoactive surfaces produced in Example 2.1 with the photosensitizer SAPN-19c and SAPN-19 were additionally stored openly in rooms with normal office lighting (standard fluorescent lamps, Osram Cool White, 840). The phototoxic effect on S. aureus was analyzed after defined times using the same bacterial counts as in Example 3. The photoactive layers were kept approximately 40 cm from the light source.
[0270] It was shown that for the photosensitizer SAPN-19c, after storage for 24 h under standard office lighting conditions with an illumination duration of 12 h, a complete killing of all germs on the surface had occurred (approx. 5.5 log 10 levels, corresponding to > 99.999% reduction). Example 5: Long-term test on photoactive stability
[0271] To test the stability of the produced paints, a long-term test was carried out.
[0272] The test surfaces were pre-irradiated for different times (5, 25, 50, 75 h) at a power of 5 mW cm -2< to determine whether the respective photosensitizer in PUR is influenced to reduce the phototoxic activity of the surface: Applied energy [J cm -2< 5 mW cm -2< 0.7 mW cm -2 "Irradiation Days" 90 5 h 35,70 h 7 days (d) 450 25 h 178,5 h 36 d 900 50 h 357,0 h 71 d 1350 75 h 535,5 h 107 d
[0273] Following pre-irradiation, the surfaces were treated with S as described above. aureuscontaminated, then irradiated for 2 h (corresponding to 5 mW cm -2< ) and the phototoxic effectiveness was measured. TPP Sensitizer WBII / 2 SAPN-19c Amount used: 5 10 -4< mol / L Amount used: 5 10 -4< mol / L
[0274] The TPP sensitizer WBII / 2 was prepared according to the procedure described in Felgenträger A., Maisch T., Späth A., Schröder JA, Bäumler W., "Singlet oxygen generation in porphyrin-doped polymeric surface coating enables antimicrobial effects on Staphylococcus aureus.", (Phys Chem Chem Phys. 2014 Oct 14;16(38):20598-607. doi: 10.1039 / c4cp02439g.).
[0275] For the porphyrin-doped surfaces tested (TPP sensitizer WBII / 2), a noticeable reduction in phototoxic efficacy was observed. After just one month, the test surfaces showed significant discoloration and a loss of phototoxic efficacy.
[0276] This can be explained by the fact that the ring of the dye breaks under the influence of the active oxygen, forming billirubin analogues:
[0277] For SAPN-19c, no difference in phototoxic effectiveness was observed up to a pre-irradiation of 75 h with 5 mW cm -2< .
[0278] This corresponds to an extrapolated 312 days of exposure (d) assuming that office fluorescent tubes are used continuously at a power of 100 µW cm -2< (at office workplace) for 12 hours of exposure per day.
Claims
1. Photosensitizer composition comprising (a) at least one phenalen-1-one compound having the general formula (1): where the R1 to R8 radicals, which may each independently be the same or different, are each hydrogen, halogen, alkyl having 1 to 12 carbon atoms, alkylaryl having 5 to 20 carbon atoms, aryl having 5 to 20 carbon atoms, *-O-alkyl having 1 to 12 carbon atoms, *-O-alkylaryl having 5 to 20 carbon atoms, *-O-aryl having 5 to 20 carbon atoms, ethers having 2 to 12 carbon atoms, a radical of the formula *-O-C(=O)-R(Ia), a radical of the formula *-C (=O)-R(Ib), or an organic radical W1 containing at least one reactive functional group, with the proviso that at least one of the R1 to R7 radicals is an organic radical W1, where the organic radical W1 is in each case independently a radical having the general formula (2) to (6): *-[(C(D) (E))d-B]a-(C(D) (E)m-X (2) *-A-[(C(D)(E))d-B]c-(C(D)(E))m-X (3) *-(C(D)(E))d-Ar-(C(D)(E))n-X (4) *-[(C(D)(E))d-B]b-(C(D)(E))g-Ar-(C(D)(E))n-X (5) *-A-[(C(D) (E))d-B]f-(C(D) (E))g-Ar-(C(D)(E))n-X (6) where A is in each case independently oxygen, sulfur, or a radical having the general formula (10a) to (11a) where *ph in each case denotes a point of attachment of the radical having the general formula (10a) to (11a) to a carbon atom of the phenalene ring and *c in each case denotes a point of attachment of the radical having the general formula (10a) to (11a) to a carbon atom of the (C(D)(E)) radical, and where the B radical is in each case independently oxygen, sulfur or a radical having the general formula (10) to (14): where the R(Ia), R(Ib), R(IIa), R(12a), R(13a), R(14a) and R(14b) radicals are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, n-pentyl, phenyl or benzyl, and where phenyl or benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, amino, hydroxyl, *-O-alkyl which may be straight-chain or branched and has 1 to 3 carbon atoms, alkyl which may be straight-chain or branched and has 1 to 3 carbon atoms, hydroxyalkyl which may be straight-chain or branched and has 1 to 3 carbon atoms and 1 to 3 OH groups, haloalkyl which may be straight-chain or branched and has 1 to 3 carbon atoms and 1 to 3 halogen groups, and combinations thereof, preferably chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy and combinations thereof, where Y- is an anion which is in each case independently fluoride, chloride, bromide, iodide, sulfate, hydrogensulfate, phosphate, hydrogenphosphate, dihydrogenphosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 carbon atoms or a combination thereof, and where the D and E radicals are each independently hydrogen, halogen, hydroxyl, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, hydroxyalkyl which may be straight-chain or branched and has 1 to 5 carbon atoms and 1 to 5 OH groups, phenyl, benzyl, a radical of the formula *-L-R(II), a radical of the formula *-L-C(=L)-R(III), a radical of the formula *-(CH2)q-X, a radical of the formula *-L-(CH2)q-X, or a radical of the formula *-(CH2)s-L-(CH2)t-X, where the L radical is in each case independently oxygen or sulfur, preferably oxygen, where the R(II) and R(III) radicals are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, n-pentyl, phenyl or benzyl, and where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, the indices q, s and t are each independently an integer from 1 to 5, where the indices a, c, f, g and n are each independently an integer from 0 to 5, and where the indices b, d and m are each independently an integer from 1 to 5, where the Ar radical is in each case independently a radical of the general formula (25a) to (31): where the R25, R26, R27, R28, R29, R26a, R26b, R27a, R27b, R28a, R28b, R29a, R29b, R30a and R30b radicals are each independently hydrogen, hydroxy, amino, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, *-O-alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl or benzyl, where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, and where the R30 radical is in each case independently hydrogen or alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, and where the R33a and R33b radicals are each independently hydrogen, hydroxy, amino, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, perfluoroalkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, *-O-alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl, benzyl or, taken together, a cycloalkyl which may be straight-chain or branched and has 4 to 9 carbon atoms, or a 9H-fluoren-9-ylidene radical, and where Y- is an anion which is in each case independently fluoride, chloride, bromide, iodide, sulfate, hydrogensulfate, phosphate, hydrogenphosphate, dihydrogenphosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 carbon atoms or a combination thereof, and where the X radical is in each case independently a reactive functional group which is *-N(R(VI))(R(VII)), *-OH, *-SH, *-NCO, *-NCS, *-Si(R(VIII))(R(IX))-[O-Si(R(x))(R(XI))]p-Z or a radical having the general formula (20) to (24) : where the R(20a), R(20b), R(20c), R(21a), R(22a), R(22b), R(22c), R(23a), R(24a), R(24b) and R(24c) radicals are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or n-pentyl, and where the indices 1 and k are each independently an integer from 0 to 4, where the R(VI) and R(VII) radicals are each independently hydrogen, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl or benzyl, where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, where the R(VIII), R(IX), R(x) and R(XI) radicals are each independently hydrogen, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, *-O-alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl or benzyl, where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, where the Z radical is in each case independently halogen, hydroxy, alkoxy having 1 to 4 carbon atoms or alkylcarboxy having 1 to 4 carbon atoms, preferably halogen or hydroxy, and where the index p is in each case independently an integer from 0 to 4, and (b) at least one polymeric component and / or precursor thereof.
2. Photosensitizer composition according to Claim 1, wherein the at least one organic radical W1 is in each case independently a radical of the general formula (40) to (67) or (72) to (98e): where Y- is an anion which is in each case independently fluoride, chloride, bromide, iodide, sulfate, hydrogensulfate, phosphate, hydrogenphosphate, dihydrogenphosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 carbon atoms or a combination thereof.
3. Photosensitizer composition according to either of Claims 1 and 2, comprising: (a) at least one phenalen-1-one compound having the general formula (1) which is selected from the group consisting of compound of the formula (100) to (127), (132) to (166): and combinations thereof, and (b) at least one polymeric component and / or precursor thereof.
4. Phenalen-1-one compound having the general formula (1a) : where the R1a to R8a radicals, which may each independently be the same or different, are each hydrogen, halogen, alkyl having 1 to 12 carbon atoms, alkylaryl having 5 to 20 carbon atoms, aryl having 5 to 20 carbon atoms, *-O-alkyl having 1 to 12 carbon atoms, *-O-alkylaryl having 5 to 20 carbon atoms, *-O-aryl having 5 to 20 carbon atoms, ethers having 2 to 12 carbon atoms, a radical of the formula *-O-C(=O)-R(Ia), a radical of the formula *-C (=O)-R(Ib), or an organic radical W1a containing at least one reactive functional group, with the proviso that at least one of the R1a and R2a radicals is an organic radical W1a, where the at least one organic radical W1a is in each case independently a radical having the general formula (41) to (67) or (98a) to (98e) : and where the R(Ia) and R(Ib) radicals are each independently methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, n-pentyl, phenyl or benzyl, and where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof.
5. Phenalen-1-one compound according to Claim 4, where the at least one phenalen-1-one compound having the general formula (1a) is selected from the group consisting of compound of the formula (101) to (127), (162) to (166) and combinations thereof:
6. Photosensitizer composition according to any of Claims 1 to 3, comprising: (a) at least one phenalen-1-one compound having the general formula (1), which is a phenalen-1-one compound according to either of Claims 4 and 5, and (b) at least one polymeric component and / or precursor thereof.
7. Photosensitizer composition according to any of Claims 1 to 3 or 6, wherein the at least one polymeric component and / or precursor thereof is selected from the group consisting of polymers and / or copolymers of acrylic acid and esters thereof, methacrylic acid and esters thereof, cyanoacrylic acid and esters thereof, acrylamide, methacrylamide, styrene, siloxanes and esters thereof, melamine, acrylonitrile, 1,3-butadiene, epichlorohydrin, polyols, polyisoprenes, polyethers, polyetherimides, polyvinylacetates, polycarbonates, polyether sulfones, carboxymethylcellulose, alginate, and combinations thereof.
8. Photosensitizer composition according to any of Claims 1 to 3 or 6 and 7, wherein the composition further comprises a crosslinking agent which is a polyisocyanate, a blocked isocyanate, an alkyl diisocyanate or cycloalkyl diisocyanate or aryl diisocyanate, a compound of the general formula SiZ4, (RXII)SiZ3, (RXII)2SiZ2, a compound having at least two epoxy radicals, a compound having at least two acrylamide radicals, a compound having at least two acrylate radicals, a compound having at least two aldehyde radicals, a compound having at least two alcohol groups, a compound having at least two amine radicals, a divinyl sulfone, or a combination thereof, where the RXII radical is in each case independently alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl or benzyl, preferably methyl, ethyl, n-propyl, isopropyl, phenyl or benzyl, and where the Z radical is in each case independently halogen, hydroxy, alkoxy having 1 to 4 carbon atoms or alkylcarboxy having 1 to 4 carbon atoms, preferably halogen or hydroxy.
9. Photosensitizer composition according to any of Claims 1 to 3 and 6 to 8, wherein the at least one phenalen-1-one compound having the general formula (1) is bonded covalently and / or electrostatically, preferably covalently, to the at least one polymeric component and / or precursor thereof.
10. Photosensitizer composition according to any of Claims 1 to 3 and 6 to 9, wherein the photosensitizer composition is a lacquer, a varnish, an emulsion paint, a latex paint, a silicate paint, or a limewash.
11. Photosensitizer composition according to any of Claims 1 to 3 and 6 to 10, wherein the photosensitizer composition is a pelletized material.
12. Article comprising at least one cured polymer composition, wherein the cured polymer composition comprises (a) at least one phenalen-1-one compound having the general formula (1): where the R1 to R8 radicals, which may each independently be the same or different, are each hydrogen, halogen, alkyl having 1 to 12 carbon atoms, alkylaryl having 1 to 18 carbon atoms, aryl having 5 to 20 carbon atoms, *-O-alkyl having 1 to 12 carbon atoms, *-O-alkylaryl having 1 to 18 carbon atoms, *-O-aryl having 5 to 20 carbon atoms, ethers having 2 to 12 carbon atoms, a radical of the formula *-O-C(=O)-R(Ia), a radical of the formula *-C (=O)-R(Ib), or an organic radical W1 containing at least one reactive functional group, with the proviso that at least one of the R1 to R7 radicals is an organic radical W1, where the organic radical W1 is in each case independently a radical having the general formula (2) to (6): *-[(C(D)(E))d-B]a-(C(D)(E)m-X (2) *-A-[(C(D)(E))d-B]c-(C(D) (E))m-X (3) *-(C(D) (E))d-Ar-(C(D)(E))n-X (4) *-[(C(D)(E))d-B]b-(C(D)(E))g-Ar-(C(D)(E))n-X (5) *-A-[(C(D)(E))d-B]f-(C(D)(E))g-Ar-(C(D)(E))n-X (6) where the A radical is in each case independently oxygen, sulfur, or a radical having the general formula (10a) to (11a) where *ph in each case denotes a point of attachment of the radical having the general formula (10a) to (11a) to a carbon atom of the phenalene ring and *c in each case denotes a point of attachment of the radical having the general formula (10a) to (11a) to a carbon atom of the (C(D)(E)) radical, and where the B radical is in each case independently oxygen, sulfur or a radical having the general formula (10) to (14): where the R(Ia), R(Ib), R(11a), R(12a), R(13a), R(14a) and R(14b) radicals are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, n-pentyl, phenyl or benzyl, and where phenyl or benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, amino, hydroxyl, *-O-alkyl which may be straight-chain or branched and has 1 to 3 carbon atoms, alkyl which may be straight-chain or branched and has 1 to 3 carbon atoms, hydroxyalkyl which may be straight-chain or branched and has 1 to 3 carbon atoms and 1 to 3 OH groups, haloalkyl which may be straight-chain or branched and has 1 to 3 carbon atoms and 1 to 3 halogen groups, and combinations thereof, preferably chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy and combinations thereof, where Y- is an anion which is in each case independently fluoride, chloride, bromide, iodide, sulfate, hydrogensulfate, phosphate, hydrogenphosphate, dihydrogenphosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 carbon atoms or a combination thereof, and where the D and E radicals are each independently hydrogen, halogen, hydroxyl, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, hydroxyalkyl which may be straight-chain or branched and has 1 to 5 carbon atoms and 1 to 5 OH groups, phenyl, benzyl, a radical of the formula *-L-R(II), a radical of the formula *-L-C(=L)-R(III), a radical of the formula *-(CH2)q-X, a radical of the formula *-L-(CH2)q-X, or a radical of the formula *-(CH2)s-L-(CH2)t-X, where the L radical is in each case independently oxygen or sulfur, preferably oxygen, where the R(II) and R(III) radicals are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, n-pentyl, phenyl or benzyl, and where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, the indices q, s and t are each independently an integer from 1 to 5, where the indices a, c, f, g and n are each independently an integer from 0 to 5, and where the indices b, d and m are each independently an integer from 1 to 5, where the Ar radical is in each case independently a radical of the general formula (25a) to (31): where the R25, R26, R27, R28, R29, R26a, R26b, R27a, R27b, R28a, R28b, R29a, R29b, R30a and R30b radicals are each independently hydrogen, hydroxy, amino, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, *-O-alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl or benzyl, where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, and where the R30 radical is in each case independently hydrogen or alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, and where the R33a and R33b radicals are each independently hydrogen, hydroxy, amino, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, perfluoroalkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, *-O-alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl, benzyl or, taken together, a cycloalkyl which may be straight-chain or branched and has 4 to 9 carbon atoms, or a 9H-fluoren-9-ylidene radical, and where Y- is an anion which is in each case independently fluoride, chloride, bromide, iodide, sulfate, hydrogensulfate, phosphate, hydrogenphosphate, dihydrogenphosphate, at least one carboxylate anion of a carboxylic acid having 1 to 15 carbon atoms, at least one sulfonate anion of a sulfonic acid having 1 to 12 carbon atoms or a combination thereof, and where the X radical is in each case independently a reactive functional group which is *-N(R(VI))(R(VII)), *-OH, *-SH, *-NCO, *-NCS, *-Si(R(VIII))(R(IX))-[O-Si(R(X))(R(XI))]p-Z or a radical having the general formula (20) to (24) : where the R(20a), R(20b), R(20c), R(21a), R(22a), R(22b), R(22c), R(23a), R(24a), R(24b) and R(24c) radicals are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or n-pentyl, and where the indices 1 and k are each independently an integer from 0 to 4, where the R(VI) and R(VII) radicals are each independently hydrogen, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl or benzyl, where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, where the R(VIIII), R(IX), R(X) and R(XI) radicals are each independently hydrogen, alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, *-O-alkyl which may be straight-chain or branched and has 1 to 5 carbon atoms, phenyl or benzyl, where phenyl and benzyl may each independently be unsubstituted or substituted by one or more radicals selected from the group consisting of chlorine, bromine, fluorine, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, and combinations thereof, where the Z radical is in each case independently halogen, hydroxy, alkoxy having 1 to 4 carbon atoms or alkylcarboxy having 1 to 4 carbon atoms, preferably halogen or hydroxy, and where the index p is in each case independently an integer from 0 to 4, and (b) at least one cured polymeric component, wherein the at least one phenalen-1-one compound having the general formula (1) is bonded covalently and / or electrostatically, preferably covalently, to the at least one cured polymeric component.
13. Article according to Claim 12, wherein the cured polymer composition comprises (a) at least one phenalen-1-one compound having the formula (1), at least one phenalen-1-one compound according to either of Claims 4 and 5 or a combination thereof, and (b) at least one cured polymeric component, wherein the at least one phenalen-1-one compound having the formula (1), the at least one phenalen-1-one compound according to either of Claims 5 and 6 or a combination thereof is bonded covalently and / or electrostatically, preferably covalently, to the at least one cured polymeric component.
14. Article according to either of Claims 12 and 13, wherein the cured polymer composition is in the form of a coating, a self-supporting film, a fabric or a shaped article.
15. Non-medical use of a photosensitizer composition according to any of Claims 1 to 3 and 6 to 11 and / or of a phenalen-1-one compound according to either of Claims 4 and 5 and / or of an article according to any of Claims 12 to 14 for inactivation, preferably photodynamic inactivation, of microorganisms preferably selected from the group consisting of viruses, archaea, bacteria, bacterial spores, biofilms of bacteria, fungi, fungal spores, protozoa, algae and blood-transmissible parasites, and / or a biofilm thereof.
16. Non-medical use of a photosensitizer composition according to any of Claims 1 to 3 and 6 to 11 and / or of a phenalen-1-one compound according to either of Claims 4 and 5 for photodynamic surface cleaning and / or surface coating of an article or space.
17. Non-medical use according to either of Claims 15 and 16 for surface coating of articles, preferably medical products, food packaging, packaging films, textiles, building materials, toys, electronic devices, furniture or hygiene articles.
18. Non-medical method for inactivation, preferably photodynamic inactivation, of microorganisms which preferably comprise viruses, archaea, bacteria, bacterial spores, biofilms of bacteria, fungi, fungal spores, protozoa, algae and blood-transmissible parasites or combinations thereof, and / or a biofilm thereof, wherein the method comprises the following steps: (A) contacting the microorganisms and / or a biofilm thereof with at least one coating that has been produced by curing a photosensitizer composition according to any of Claims 1 to 3 and 6 to 11 and / or contains at least one phenalen-1-one compound according to either of Claims 4 and 5, and / or at least one article according to any of Claims 12 to 14, and (B) irradiating the microorganisms and / or a biofilm thereof and the at least one phenalen-1-one compound present in the coating and / or the article with electromagnetic radiation of suitable wavelength and energy density.
